rfhg_148565.1

Basic information about the TSS

---

TSS ID: rfhg_148565.1 TSS ID(Version3): hg_124707.1 hg_124709.1 hg_124708.1 hg_124706.1 Species: human Chr: chr12		Start: 22625139 End: 22625240 Strand: +
Source datasets	FANTOM5|PRJNA4843412|DRA013844|PRJNA597322|PRJNA401781 |PRJNA548673|PRJNA615891
Protocol	CAGE|NETCAGE|STRIPE-seq|ReCappable-seq|SLIC_CAGE |oligo_capping|TIF-seq2
TSS cluster detected*	10

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2538271,EH38E1598435)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000335148.8:0 ENST00000672951.1:0 ENST00000266517.9:0 ENST00000538218.2:0 BC066907:0 CU688188:0 JF432382:0 BC006111:0 AL137750:0 AK074425:0 GeneID: 55500 HGNC/MGI_ID: HGNC:24649 UniProt_ID: A0A5K1VW28 H0YH69 Q659C5 Q86U68 Q9HBU6 Nearer transcript ids and distances: ENST00000671733.1:-64 AF207600:-64 ENST00000545979.2:117 ENST00000673496.1:142 KJ906228:188 BT007084:191 ENST00000673406.1:311 view more...

Gene_name: ethanolamine kinase 1 Gene_symbol: ETNK1 Gene_synonyms: EKI EKI1 Gene_source: HGNC:24649

TATA-Box annotation

---

Distance to TSS:	18
Nearest PromoterID:	NM_001039481
Entrez ID:	55500
Nearest Unigene:	Hs.29464
Nearest Refseq:	NM_018638
Nearest Ensembl:	ENSG00000139163
Gene Name:	ethanolamine kinase 1
Gene Alias:	EKI|EKI 1|EKI1|Nbla10396
Gene Type:	protein-coding
CpG%:	0.108911
GC%:	0.696078
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ETNK1 p2@ETNK1 p3@ETNK1 p4@ETNK1 p5@ETNK1 p7@ETNK1
Sample		p1@ETNK1	p2@ETNK1	p3@ETNK1	p4@ETNK1	p5@ETNK1	p7@ETNK1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	18.51	22.21	15.39	17.14	2.92	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	19.83	17.60	17.40	12.14	2.02	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	15.05	20.25	20.45	18.52	2.51	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	16.22	19.54	13.31	14.35	2.29	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	17.32	18.90	15.97	18.45	3.15	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	16.28	19.77	18.99	18.80	2.52	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	17.43	19.39	15.47	14.38	3.05	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	15.74	18.65	15.26	14.05	3.15	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	18.17	16.46	8.98	15.60	1.50	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	21.45	33.62	20.29	37.10	4.64	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	21.83	26.68	23.85	42.44	3.64	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	24.39	32.12	19.11	38.62	4.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	30.63	24.02	8.38	6.45	3.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	19.09	16.84	9.77	5.71	2.41	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	27.22	20.86	5.27	4.61	3.07	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	27.16	16.35	8.05	4.78	4.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	19.00	15.29	6.33	4.59	2.40	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	21.51	12.23	14.34	5.91	2.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	16.53	21.33	9.06	4.80	2.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	23.17	20.31	6.17	4.66	1.65	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	23.66	18.84	6.55	5.08	2.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	20.71	17.43	5.87	5.01	2.59	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	22.75	15.64	8.27	3.88	3.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	23.54	20.63	8.25	6.07	2.18	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	26.06	19.87	8.77	4.64	3.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	21.52	25.00	6.65	4.43	2.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	28.57	17.03	8.79	3.85	2.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	21.22	17.68	4.01	6.13	2.36	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	19.71	18.58	6.30	3.88	2.75	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	24.43	19.36	6.33	4.16	3.08	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	24.28	15.07	7.75	4.19	2.51	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	25.79	24.23	5.28	5.08	3.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	24.48	16.46	10.76	3.38	2.53	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	20.12	16.66	10.89	3.79	1.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	20.94	18.14	4.86	6.36	2.24	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	23.95	21.85	5.75	6.90	4.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	23.30	19.21	3.47	6.54	3.27	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	27.81	14.10	3.83	5.24	1.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	26.47	17.83	4.86	7.02	3.24	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	24.73	17.04	6.00	3.60	2.16	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	18.11	15.29	6.82	3.29	3.76	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	16.10	14.64	5.71	3.37	2.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	19.19	14.97	3.80	3.16	3.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	21.15	15.91	3.67	6.12	3.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	20.68	20.28	4.02	5.22	3.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	19.77	16.29	5.12	5.35	3.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	24.47	15.59	3.84	5.04	1.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	24.14	13.41	3.58	5.07	4.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	20.59	17.23	3.83	4.07	1.20	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	19.61	13.14	3.64	4.04	1.42	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	23.16	15.37	6.15	5.94	1.64	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	17.79	14.45	10.90	5.34	2.67	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	83.95	13.99	1595.11	27.98	13.99	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	19.52	7.10	8.87	4.97	3.19	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	15.91	10.27	7.29	4.64	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	12.58	10.07	71.31	8.39	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	9.64	8.73	16.07	5.05	1.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	17.83	9.08	2.59	5.51	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	12.53	8.67	11.24	4.82	2.25	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	8.49	10.37	9.43	2.20	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	14.10	9.87	7.05	0.71	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	14.58	10.65	6.73	3.36	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	14.33	12.74	31.85	3.18	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	9.85	13.93	9.85	2.72	2.38	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	17.22	14.95	8.77	5.52	1.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	11.00	10.29	12.07	3.19	3.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	64.66	2343.77	16.16	0.00	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	39.49	1263.60	15.79	15.79	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	12.68	9.26	7.31	0.49	2.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	9.92	10.91	11.41	2.48	2.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.79	11.73	4.69	2.81	1.88	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	12.59	11.92	8.61	1.99	3.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	12.68	9.59	8.35	2.17	1.86	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	17.12	11.92	11.31	3.06	2.45	0.31
Adipocyte - breast, donor1	11376-118A8	10.45	8.24	5.39	2.85	0.95	0.00
Adipocyte - breast, donor2	11327-117E4	7.22	4.33	3.53	2.57	0.32	0.00
Adipocyte - omental, donor1	11473-119C6	11.83	9.67	6.36	8.27	1.53	0.25
Adipocyte - omental, donor2	11474-119C7	3.74	4.48	2.24	8.97	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	11.05	5.69	4.02	2.68	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	7.66	4.47	3.19	1.28	1.91	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	4.40	0.00	1.10	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	5.42	3.16	1.81	3.16	1.35	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	9.04	5.39	2.43	1.56	0.35	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	10.56	6.26	4.30	2.74	1.76	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	7.72	9.01	0.77	2.83	1.54	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	6.41	8.64	1.95	3.07	1.39	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	14.11	11.76	0.59	2.35	3.53	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	8.69	8.20	2.49	2.82	1.45	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	8.71	8.71	1.61	1.94	0.97	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	6.40	3.73	3.73	2.67	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	12.80	6.12	0.56	2.23	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	6.65	8.73	1.25	0.83	1.25	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	5.78	5.02	2.51	2.51	1.26	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	7.53	7.20	2.29	3.60	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	3.96	4.57	1.22	4.57	0.91	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	5.52	5.75	1.55	2.21	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	2.15	1.43	0.00	0.36	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	7.20	5.40	1.98	1.26	0.90	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	1.67	5.02	3.35	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	3.90	2.88	2.47	0.82	0.82	0.00
Anulus Pulposus Cell, donor1	11248-116E6	13.96	8.01	2.86	1.72	0.69	0.11
Anulus Pulposus Cell, donor2	11463-119B5	11.51	7.59	2.45	0.73	1.47	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	8.54	7.64	4.49	2.25	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	7.38	5.21	5.64	1.30	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	4.28	14.98	6.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	4.78	6.58	3.89	2.69	1.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	5.06	3.79	5.06	1.26	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	3.30	5.28	6.60	0.66	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	4.22	5.52	6.17	4.22	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	5.83	4.85	5.83	3.40	1.46	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	7.72	2.97	3.56	2.38	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	5.65	5.27	4.14	1.88	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	4.35	5.81	7.98	2.18	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	6.27	5.02	5.02	2.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	7.08	4.61	2.80	2.31	0.49	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	2.73	5.46	2.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	6.79	4.98	6.18	2.87	0.75	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	4.82	5.89	5.36	4.82	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	4.53	7.37	3.97	1.51	0.94	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	8.02	5.08	3.74	1.60	1.87	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	6.83	8.78	6.83	5.85	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	5.64	3.81	3.48	1.99	1.49	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	7.20	4.80	4.80	3.60	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	0.00	7.08	7.08	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	7.03	5.49	3.60	2.74	0.69	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	7.28	2.43	5.34	4.37	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	4.55	4.17	3.04	3.04	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	8.48	4.85	4.85	2.42	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.12	11.40	3.42	2.85	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	4.70	5.99	2.99	2.57	1.07	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	5.16	5.94	3.61	1.81	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	4.22	6.57	5.16	3.28	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	7.40	5.14	7.40	2.89	0.96	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	5.71	5.71	1.43	2.14	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	3.51	4.09	4.09	4.09	1.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	6.62	5.12	3.01	0.90	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	7.13	4.75	5.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	6.61	5.09	5.09	2.54	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	7.39	4.84	3.57	2.29	0.51	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	4.45	3.18	3.81	1.91	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	8.20	6.90	3.45	2.59	0.86	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	5.29	6.35	3.39	2.54	1.06	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.64	5.22	4.93	1.16	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	7.56	7.56	1.89	0.94	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	6.44	5.09	2.71	1.70	0.85	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	0.00	2.32	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	6.34	4.23	4.23	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	6.65	6.00	2.36	0.64	1.29	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	3.01	3.01	6.02	1.80	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	3.64	8.02	5.10	5.10	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.29	3.68	1.84	1.15	1.61	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	5.10	7.65	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	6.10	6.86	4.83	1.78	0.76	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	5.99	6.19	2.89	2.48	0.83	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	6.12	4.28	3.06	1.53	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	4.78	5.74	7.65	3.82	1.43	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	4.88	5.32	4.43	2.22	1.33	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	6.10	4.58	1.53	6.10	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.31	6.65	1.11	2.22	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	7.41	3.71	1.85	1.06	2.12	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.82	4.72	3.27	1.45	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	10.56	5.77	2.46	1.72	0.25	0.12
Astrocyte - cerebellum, donor2	11580-120F5	8.22	4.28	1.37	1.71	0.51	0.00
Astrocyte - cerebellum, donor3	11661-122F5	3.99	1.68	0.21	0.84	0.63	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	28.58	19.52	14.29	4.53	2.79	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	22.16	16.18	9.06	7.77	2.43	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	22.22	15.36	8.35	4.18	2.68	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	51.15	24.54	29.13	4.47	1.49	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	43.47	22.93	24.18	4.64	1.63	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	39.37	22.53	29.02	3.07	2.39	0.46
Basophils, donor1	12241-129G9	12.03	8.89	1.57	8.37	1.57	0.78
Basophils, donor2	12242-129H1	14.79	15.15	2.16	9.38	0.72	0.00
Basophils, donor3	12243-129H2	11.47	10.88	0.59	7.20	2.35	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	3.45	1.51	1.29	2.16	0.65	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	1.83	1.83	0.00	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	3.77	3.14	1.26	1.26	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	1.25	1.66	0.00	1.04	0.62	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	2.07	2.76	0.46	1.15	0.46	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	6.30	6.30	5.22	2.16	1.08	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	34.42	12.26	10.92	2.16	0.62	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	64.51	15.60	25.15	3.03	2.10	1.86
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	40.29	16.95	7.04	2.56	0.64	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	10.71	13.53	0.00	14.09	2.25	0.56
CD14+ Monocytes, donor2	11305-117B9	15.40	15.59	1.86	13.36	2.23	1.30
CD14+ Monocytes, donor3	11381-118B4	13.61	13.83	2.63	12.07	2.63	1.54
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	48.40	38.49	23.21	12.45	3.11	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	49.28	45.49	12.51	17.06	4.55	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	47.67	38.13	25.64	13.15	5.59	2.30
CD14+ monocytes - mock treated, donor1	11863-125A9	14.02	15.76	6.79	7.52	2.46	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	8.15	11.16	2.72	6.94	0.60	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	13.50	18.48	5.45	10.42	1.42	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	11.55	15.74	6.03	8.70	2.18	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	10.49	15.46	3.86	13.52	4.69	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	12.40	18.35	6.69	16.12	1.98	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	9.01	21.73	8.62	14.29	2.94	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	13.00	21.72	5.34	14.42	3.92	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	18.72	29.16	8.71	23.94	3.70	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	11.24	19.43	5.62	14.75	2.58	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	19.01	20.59	4.75	18.48	3.70	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	11.09	27.73	8.87	22.19	4.44	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	12.35	16.06	8.03	5.80	1.93	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	10.98	15.76	5.19	9.98	1.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	13.32	22.90	4.58	11.45	2.71	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	12.58	21.05	7.55	13.04	4.35	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	12.44	19.91	2.49	17.42	2.94	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	9.60	18.33	6.55	19.20	3.93	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	14.79	19.37	2.96	11.84	3.77	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	15.35	17.79	7.15	14.48	5.06	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	15.15	19.78	8.42	16.83	4.63	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	12.12	18.74	6.43	14.15	3.49	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	11.98	16.20	2.11	15.15	2.47	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	15.79	21.06	3.51	21.50	3.07	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	11.68	22.15	10.11	16.74	3.84	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	11.52	20.07	5.95	11.89	3.72	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	17.24	25.43	4.74	24.57	3.45	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	12.69	18.84	5.32	13.51	3.28	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	15.53	18.54	4.17	19.93	2.32	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	12.99	24.82	5.57	19.49	4.18	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	19.40	22.89	4.58	11.99	4.58	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	18.48	22.87	4.85	15.25	3.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	17.33	21.23	3.47	8.88	2.60	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	27.87	28.50	5.92	13.55	3.58	1.25
CD14+CD16- Monocytes, donor2	11799-124C8	24.10	22.01	5.41	10.13	1.40	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	29.21	21.41	3.57	4.68	3.34	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	18.12	22.46	6.12	18.88	4.34	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	21.08	23.05	3.07	16.91	3.07	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	14.74	18.95	7.16	10.74	3.16	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	63.00	26.42	8.13	4.06	2.03	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	55.59	25.09	12.20	2.71	1.36	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	62.14	25.89	8.28	1.04	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	83.69	41.04	22.39	3.73	2.13	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	52.00	18.23	16.08	1.61	1.07	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	56.16	25.97	4.91	2.81	1.40	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	67.45	25.10	9.41	1.57	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	52.73	19.77	6.59	1.32	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	53.42	24.66	17.26	2.47	4.93	0.82
CD19+ B Cells, donor2	11624-122B4	39.17	21.76	7.98	5.80	2.18	1.45
CD19+ B Cells, donor3	11705-123B4	32.81	18.17	5.05	3.53	0.00	2.52
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	38.39	29.09	19.80	5.25	2.42	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	35.55	31.16	17.18	1.60	1.60	0.80
CD34+ Progenitors, donor1	11545-120B6	33.13	22.09	2.01	5.02	2.01	0.00
CD34+ Progenitors, donor2	11625-122B5	28.65	16.29	0.56	8.43	2.25	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	51.48	15.41	14.65	1.13	0.75	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	40.59	16.46	6.31	2.71	0.68	0.00
CD4+ T Cells, donor1	11225-116C1	44.63	19.64	2.86	7.86	0.00	0.36
CD4+ T Cells, donor2	11306-117C1	34.90	17.15	7.35	5.51	1.22	3.67
CD4+ T Cells, donor3	11382-118B5	21.96	13.72	6.71	7.01	1.52	3.05
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	84.99	52.83	9.44	18.89	3.83	1.79
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	72.99	49.41	22.46	12.58	4.49	2.92
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	88.25	48.58	23.86	12.36	4.60	2.87
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	60.68	36.03	2.84	3.32	1.42	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	87.09	47.76	2.81	7.73	0.00	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	56.04	42.85	6.59	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	47.83	25.87	11.85	5.49	2.75	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	59.31	29.32	21.86	9.83	2.88	2.71
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	50.13	33.85	19.51	10.16	2.58	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	48.42	26.45	7.62	6.28	0.90	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	58.70	28.30	5.59	2.45	1.40	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	67.32	34.76	7.92	4.40	2.64	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	63.67	24.46	17.29	4.64	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	38.23	20.15	16.41	2.08	2.08	1.87
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	38.76	16.37	13.03	3.34	0.33	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	75.05	26.92	10.06	2.99	1.36	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	84.68	28.94	6.43	3.22	0.54	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	52.00	23.31	3.59	5.38	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	65.64	29.30	15.39	4.64	0.74	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	48.96	22.96	6.28	3.25	2.17	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	51.70	26.48	9.46	3.57	1.89	1.47
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	54.10	28.82	5.06	3.54	0.51	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	55.02	37.26	2.17	3.47	1.73	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	59.27	34.43	10.02	4.79	1.31	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	75.22	40.08	11.38	2.47	1.48	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	56.31	15.69	13.85	0.92	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	48.85	27.92	13.96	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	85.29	33.79	9.14	4.15	0.55	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	82.70	39.02	8.83	1.23	1.47	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	60.06	24.64	15.40	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	65.54	35.45	12.18	2.15	1.07	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	51.24	29.08	8.31	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	30.78	23.57	3.27	8.18	1.96	0.65
CD8+ T Cells, donor2	11307-117C2	32.66	25.53	4.51	10.14	1.50	1.88
CD8+ T Cells, donor3	11383-118B6	26.76	23.23	6.31	7.07	2.78	4.04
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	12.39	8.03	4.13	2.29	0.92	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	15.10	8.39	4.07	0.72	1.20	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	13.95	9.30	7.66	2.19	0.82	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	18.91	9.61	4.80	1.20	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	17.28	8.64	5.28	3.12	1.20	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	13.64	8.87	3.87	1.82	0.23	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	19.12	8.91	7.60	2.61	1.52	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	21.58	12.63	5.00	1.84	1.05	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	18.06	11.26	7.27	1.88	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	20.53	13.89	12.38	5.74	0.60	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	25.85	13.65	5.52	3.78	1.45	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	19.18	13.59	2.93	3.20	0.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	32.39	24.08	13.13	24.95	3.06	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	29.60	22.32	10.47	22.77	4.10	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	23.87	23.12	11.19	22.38	1.49	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	15.49	8.28	7.56	2.16	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	14.67	9.21	7.19	3.45	1.15	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	12.26	6.84	4.95	1.65	0.47	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	19.01	12.04	6.97	2.22	1.90	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	20.30	12.61	8.92	2.15	0.92	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	20.52	10.90	6.09	1.92	1.60	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	16.45	10.71	6.12	4.59	2.68	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	24.83	10.64	6.70	4.73	0.79	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	11.35	9.08	7.56	2.27	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	40.95	28.91	14.45	17.67	4.01	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	32.87	32.87	17.49	35.67	3.50	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	29.05	24.04	22.04	32.06	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	16.45	5.48	1.83	9.14	3.66	0.00
Cardiac Myocyte, donor2	11605-120I3	7.41	7.41	4.94	4.45	1.48	0.00
Cardiac Myocyte, donor3	11686-122I3	10.73	4.00	3.05	2.10	1.05	0.00
Chondrocyte - de diff, donor1	11261-116G1	6.59	4.85	5.20	4.51	1.73	0.00
Chondrocyte - de diff, donor2	11338-117F6	4.26	2.84	0.71	1.42	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	6.60	6.03	4.44	2.62	1.25	0.00
Chondrocyte - re diff, donor2	11339-117F7	5.37	2.69	0.00	0.90	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	7.68	9.71	2.43	12.13	1.21	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	25.82	18.94	9.18	5.39	2.52	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	16.03	10.47	11.33	4.49	2.78	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	19.82	14.87	9.82	4.51	2.39	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	50.25	31.09	5.04	8.62	1.83	0.28
Corneal Epithelial Cells, donor1	11526-119I5	2.42	0.66	0.44	0.00	0.22	0.22
Corneal Epithelial Cells, donor2	11606-120I4	3.41	0.00	1.14	1.14	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	1.53	2.56	0.51	2.30	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	29.06	22.45	8.09	9.25	4.62	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	24.60	23.66	10.09	8.83	1.26	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	20.70	3.45	3.45	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	18.57	23.65	14.47	9.61	1.94	1.19
Dendritic Cells - plasmacytoid, donor1	11228-116C4	49.20	21.18	7.52	4.44	0.34	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	58.11	24.16	5.22	3.92	0.65	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	53.72	23.23	0.97	3.39	1.45	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	7.50	6.00	1.67	0.83	1.33	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	4.11	3.52	1.17	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	6.50	3.68	0.85	1.98	1.41	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	7.47	3.93	1.97	2.75	1.18	0.00
Endothelial Cells - Artery, donor1	11264-116G4	5.82	4.94	0.00	2.04	0.87	0.00
Endothelial Cells - Artery, donor2	11341-117F9	9.88	7.06	1.88	3.06	1.41	0.24
Endothelial Cells - Artery, donor3	11413-118E9	6.14	7.19	2.45	1.40	1.23	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	16.62	10.42	8.42	3.10	0.89	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	13.39	7.91	2.74	2.43	1.22	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	21.42	10.99	3.38	1.69	1.13	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	7.13	5.65	2.67	2.08	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	10.41	3.64	2.08	3.12	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	4.25	3.83	2.41	0.71	0.43	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	10.00	11.60	4.40	4.00	2.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	5.77	4.72	3.14	3.14	2.10	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	23.98	18.64	13.67	4.72	2.73	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	18.68	11.08	2.61	3.04	1.74	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	20.40	13.43	2.32	4.52	1.83	0.00
Endothelial Cells - Vein, donor1	11267-116G7	7.96	7.96	0.00	2.28	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	6.99	9.08	1.40	4.19	3.49	0.00
Endothelial Cells - Vein, donor3	11416-118F3	8.48	5.81	2.36	3.61	0.31	0.16
Eosinophils, donor1	12244-129H3	0.00	15.25	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	24.75	46.21	0.00	29.70	6.60	0.00
Eosinophils, donor3	12246-129H5	0.00	21.40	0.00	35.67	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	4.15	2.69	1.22	0.98	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	0.00	4.16	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	4.93	2.46	2.05	4.52	0.82	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.28	2.41	1.31	2.19	0.66	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	3.03	1.08	1.08	0.98	0.11	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	7.28	6.31	2.91	3.03	0.73	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	21.02	14.88	7.10	11.05	4.91	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	5.91	4.32	2.95	2.53	1.37	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	29.51	23.98	7.90	8.43	2.37	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	12.29	4.65	5.32	2.33	1.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	5.90	5.44	1.36	2.27	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	6.06	6.82	0.76	1.52	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	4.89	3.15	1.42	1.89	1.10	0.00
Fibroblast - Cardiac, donor4	11452-119A3	16.97	8.79	2.73	5.46	1.21	0.00
Fibroblast - Cardiac, donor5	11456-119A7	12.18	10.03	5.96	3.17	2.41	0.13
Fibroblast - Cardiac, donor6	11460-119B2	9.40	10.46	5.31	3.03	1.06	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	13.80	7.10	1.88	5.36	1.21	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	11.22	8.63	3.88	6.04	2.16	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	16.11	2.93	8.79	2.93	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	6.92	9.69	2.77	6.00	2.08	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	13.57	14.76	1.87	5.43	1.36	0.17
Fibroblast - Dermal, donor1	11269-116G9	15.03	11.97	2.82	4.70	3.05	0.00
Fibroblast - Dermal, donor2	11346-117G5	6.13	5.19	0.94	2.36	1.42	0.00
Fibroblast - Dermal, donor3	11418-118F5	11.24	9.67	6.53	5.20	2.42	0.12
Fibroblast - Dermal, donor4	11450-119A1	11.64	7.69	8.03	3.39	1.24	0.11
Fibroblast - Dermal, donor5	11454-119A5	13.08	10.47	5.06	4.54	1.40	0.17
Fibroblast - Dermal, donor6	11458-119A9	14.78	10.72	7.47	3.90	2.27	0.32
Fibroblast - Gingival, donor1	11237-116D4	14.78	10.41	3.33	3.33	1.46	1.67
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	13.62	13.36	1.57	4.98	1.83	0.00
Fibroblast - Gingival, donor2	11318-117D4	12.78	11.60	7.91	2.11	2.50	0.92
Fibroblast - Gingival, donor3	11394-118C8	13.34	11.41	3.87	5.22	2.42	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	9.35	3.12	3.12	3.12	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	8.46	7.93	1.41	2.64	0.53	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	8.26	8.57	1.25	5.30	1.87	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	7.98	6.90	2.16	3.11	0.95	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	21.17	19.41	0.00	8.82	2.47	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	9.51	7.60	0.88	3.66	1.32	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	7.09	7.91	1.23	4.23	1.50	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	9.65	7.68	0.88	2.08	0.99	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	15.11	14.67	1.03	5.28	3.82	0.15
Fibroblast - Lung, donor1	11270-116H1	4.08	4.08	0.00	1.36	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	19.40	19.40	5.97	5.97	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	6.75	5.70	2.53	2.53	1.90	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	6.66	5.83	2.50	2.50	1.67	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	6.99	1.40	4.20	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.40	3.08	0.00	2.52	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	8.12	7.71	2.03	5.68	1.62	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	5.96	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	14.16	12.22	11.06	2.72	2.13	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	18.05	13.95	8.19	2.43	1.52	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	14.38	10.71	0.31	4.28	1.84	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	10.30	6.11	0.38	2.29	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	8.37	9.45	1.08	4.86	1.35	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	9.74	7.19	0.93	2.55	1.04	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	9.51	8.95	3.54	3.54	1.88	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	10.77	7.52	1.42	4.88	2.03	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	4.01	2.00	1.34	2.00	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	7.91	8.70	2.77	1.58	2.37	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	18.46	20.24	4.17	6.75	1.98	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	7.99	4.09	2.49	3.02	1.07	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	5.32	3.35	3.55	3.35	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	14.14	15.34	3.91	7.82	1.50	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	10.36	6.48	2.16	3.99	1.19	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	19.23	14.17	4.81	6.07	1.52	0.00
Fibroblast - skin normal, donor1	11553-120C5	8.53	5.09	2.46	2.95	0.16	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	21.65	15.24	8.02	6.82	2.41	0.60
Fibroblast - skin normal, donor2	11561-120D4	7.23	3.92	1.71	1.51	0.60	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	25.99	14.81	5.74	7.25	3.02	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	8.45	6.38	3.15	2.73	0.66	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	15.04	5.98	5.47	1.88	0.68	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	15.11	17.74	2.96	5.25	1.31	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	6.39	3.30	2.34	2.66	0.64	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	4.89	3.71	2.02	1.69	1.18	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	3.45	4.39	2.51	1.41	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	155.12	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	13.94	19.17	2.61	3.49	1.74	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	7.28	8.49	2.77	7.80	1.21	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	5.73	7.55	3.12	3.90	2.08	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	4.09	6.64	1.28	5.88	1.79	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	23.73	22.97	13.01	8.42	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	33.18	21.06	14.68	5.74	2.55	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	36.80	20.25	22.82	7.70	3.71	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	52.95	19.58	13.79	3.03	1.38	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	52.29	28.08	12.56	5.48	4.11	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	40.22	21.00	16.84	10.50	3.57	1.39
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	47.32	14.27	9.25	1.85	0.79	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	78.28	39.14	9.13	7.18	4.57	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	28.30	23.00	24.76	11.94	3.10	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	45.36	21.48	21.34	4.80	2.69	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	36.82	23.03	11.08	5.91	2.71	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	26.86	14.24	13.97	5.64	2.95	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	22.42	14.25	9.29	5.08	2.23	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	27.41	17.16	5.54	3.74	1.80	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	18.70	13.01	9.96	4.88	2.03	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	19.62	14.38	12.55	4.34	1.83	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	23.04	15.20	8.60	4.86	1.62	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	29.07	17.05	6.34	6.34	1.75	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	21.27	12.41	15.07	2.95	2.07	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	28.45	19.39	9.54	6.04	2.23	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	22.79	20.33	12.29	6.03	2.90	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	25.00	18.15	15.12	5.44	2.02	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	31.38	24.09	12.38	7.29	1.87	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	27.49	16.14	16.32	8.07	2.04	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	26.01	14.78	18.83	4.27	1.98	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	25.45	14.52	16.22	5.29	2.22	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	27.00	23.46	7.97	5.86	3.10	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	30.70	18.30	13.81	6.32	2.66	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	26.75	18.17	11.84	8.78	3.27	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	23.73	14.65	17.33	4.33	3.09	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	32.40	20.29	13.95	6.11	2.65	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	29.18	20.51	9.17	7.50	3.84	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	22.48	14.11	17.63	3.75	2.20	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	28.41	23.49	9.35	6.52	2.46	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	29.34	20.26	11.18	6.48	3.08	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	30.15	18.92	17.00	5.13	1.28	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	25.87	18.95	9.38	5.40	2.46	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	21.35	16.61	12.65	5.85	2.06	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	21.29	17.03	10.95	6.99	1.52	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	27.60	21.74	14.32	8.57	2.61	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	18.22	13.61	10.54	7.03	3.95	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	21.04	16.83	19.64	7.57	2.24	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	24.44	18.52	5.56	9.54	3.24	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	22.46	11.77	13.10	9.36	3.74	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	18.21	17.75	10.25	9.33	3.37	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	18.39	18.65	9.84	9.07	4.02	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	19.25	15.45	11.93	7.05	4.88	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	15.67	12.90	13.27	7.37	4.24	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	18.42	13.16	7.68	5.26	2.85	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	14.88	17.85	5.95	6.94	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	14.25	10.55	10.29	6.20	2.37	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	13.52	9.89	11.30	7.26	2.62	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	21.10	13.72	6.10	6.10	3.30	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	42.20	16.72	15.53	8.36	1.39	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	39.91	25.27	11.40	7.09	2.47	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	53.60	24.96	9.82	8.59	2.66	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	15.65	8.14	5.32	2.19	1.25	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	11.58	6.22	5.93	3.11	1.13	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	36.90	15.22	16.14	4.61	2.31	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	29.70	17.32	17.32	0.00	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	22.43	19.34	10.06	6.19	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	40.11	11.23	14.44	4.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	43.47	15.65	8.69	5.22	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	22.13	13.67	9.76	3.91	4.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	26.77	15.24	12.35	4.12	3.29	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	19.99	26.66	6.66	6.66	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	24.33	19.85	13.98	5.31	2.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	22.55	16.34	13.73	4.90	2.29	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	31.88	17.62	26.00	3.36	5.03	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	30.22	18.13	15.27	5.41	3.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	19.70	15.28	14.95	3.40	1.36	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	25.06	12.53	8.35	2.09	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	26.34	16.04	13.74	2.86	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	15.10	11.54	14.50	1.78	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	15.25	20.33	25.41	13.55	3.39	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	25.27	24.02	17.40	8.28	4.56	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	26.46	20.02	16.57	3.45	2.53	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	15.81	15.81	10.54	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	24.60	13.84	13.45	4.61	4.23	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	22.17	15.32	12.39	6.85	2.93	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	23.41	13.38	7.36	9.36	3.34	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	25.81	20.03	10.02	6.93	2.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	30.13	20.88	16.43	14.38	2.05	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	32.30	19.88	32.30	14.91	7.45	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	25.01	16.51	13.68	2.36	1.89	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	22.93	15.69	12.07	3.62	3.62	3.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	35.61	19.84	13.23	8.14	1.02	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	31.11	21.94	17.55	6.78	1.60	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	23.68	19.24	19.24	8.39	2.47	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	23.61	12.98	17.71	8.26	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	20.42	19.25	22.17	2.33	0.58	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	24.58	22.38	10.09	5.71	2.63	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	16.11	16.11	14.41	10.17	0.85	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	18.50	17.31	13.73	7.16	4.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	18.44	14.07	17.95	9.22	3.40	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	7.99	5.71	0.00	2.28	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	4.16	4.57	3.33	2.91	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	5.62	3.37	0.00	2.25	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	11.10	6.03	8.25	4.44	2.22	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	11.70	5.85	7.52	2.51	1.67	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	7.77	7.08	4.53	3.83	1.28	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	9.79	7.76	5.23	3.54	1.35	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	10.24	7.05	4.55	4.10	0.46	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	9.62	7.87	4.59	2.73	1.09	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	7.95	7.09	4.94	3.87	0.86	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	9.90	6.67	3.44	4.74	0.65	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	9.96	8.09	3.86	4.98	1.49	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	6.35	6.69	4.80	4.29	0.86	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	6.09	5.77	1.92	2.88	2.24	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	7.83	8.95	2.24	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	2.60	3.03	0.00	1.73	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	7.93	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	4.94	7.05	0.71	3.88	1.41	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.09	2.91	0.73	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	6.64	7.34	3.50	2.62	2.27	0.00
Hepatocyte, donor1	11523-119I2	21.79	24.21	16.95	21.79	2.42	0.00
Hepatocyte, donor2	11603-120I1	26.93	37.71	21.55	17.24	4.31	0.00
Hepatocyte, donor3	11684-122I1	25.16	31.90	22.09	12.88	7.36	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	67.88	13.71	6.53	1.96	0.65	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	30.76	26.04	20.27	12.76	4.37	1.40
Iris Pigment Epithelial Cells, donor1	11530-119I9	12.49	7.96	4.12	3.16	2.20	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	12.74	0.00	6.37	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	13.35	0.00	6.68	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	54.17	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	18.00	6.92	0.00	9.69	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	15.02	10.01	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	17.94	10.25	0.00	7.69	10.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	4.57	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	21.12	17.87	0.00	3.25	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	23.34	16.67	1.67	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	10.89	0.00	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	13.23	34.41	0.00	6.62	2.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	13.30	8.87	2.22	6.65	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	26.19	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	22.05	16.38	0.63	3.78	3.15	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	10.83	13.92	1.55	6.19	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	21.97	16.80	1.29	7.11	2.58	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	24.15	24.15	0.00	4.83	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	22.00	24.45	0.81	7.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	16.37	15.11	0.00	4.62	1.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	16.88	14.47	0.00	6.43	4.82	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	15.70	16.62	0.00	4.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	14.63	16.05	0.47	8.02	0.94	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	11.79	19.95	0.00	6.35	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	15.07	17.22	0.00	6.46	3.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	21.60	22.87	0.00	10.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	32.86	0.00	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	21.04	18.49	0.64	7.01	1.28	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	21.87	20.05	0.00	7.29	5.47	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	17.85	28.56	0.00	7.14	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	23.23	0.00	6.64	9.95	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	11.42	8.03	1.23	2.78	2.47	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	15.80	21.07	0.00	5.27	3.51	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	18.86	0.00	9.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	28.51	23.64	0.70	8.34	2.78	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	26.56	13.28	0.00	0.00	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	6.48	0.00	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	16.57	14.82	0.00	0.87	2.62	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	11.25	0.00	4.50	6.75	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	20.91	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	13.87	17.07	0.00	6.40	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	8.31	22.17	0.00	6.93	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	14.25	0.00	5.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	15.65	14.73	0.00	7.36	1.84	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	21.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	10.57	10.57	1.06	2.11	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	2.69	3.10	1.55	4.65	0.57	0.00
Keratinocyte - epidermal, donor2	11349-117G8	1.17	3.51	0.00	1.17	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	4.73	5.68	3.98	4.07	1.23	0.00
Keratinocyte - oral, donor1	11251-116E9	12.03	9.88	7.04	2.84	1.36	0.11
Keratocytes, donor1	11527-119I6	7.56	5.85	3.09	5.16	1.72	0.00
Keratocytes, donor2	11607-120I5	2.34	1.17	0.00	3.52	1.17	0.00
Keratocytes, donor3	11688-122I5	10.47	8.10	2.37	3.16	1.38	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	6.59	17.58	0.00	8.79	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	16.18	8.63	8.63	6.47	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	25.49	19.95	10.38	4.04	2.42	0.00
Lens Epithelial Cells, donor3	11690-122I7	16.45	10.60	2.62	6.46	2.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	7.59	6.05	1.90	0.95	1.30	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	5.58	3.91	3.91	1.95	1.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	14.48	11.02	9.92	2.83	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	3.23	2.15	1.08	1.08	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	3.78	1.26	1.58	0.32	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	3.99	2.70	1.29	0.32	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	10.26	9.44	6.57	2.87	1.23	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	4.30	3.79	2.02	0.51	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	5.49	4.50	2.82	1.69	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	8.70	4.75	5.14	3.16	1.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	7.76	4.65	5.43	2.52	1.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.89	2.22	0.74	1.30	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	9.06	9.06	5.92	3.83	1.39	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	7.16	6.68	2.86	2.15	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.59	3.71	1.37	1.24	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	7.70	8.62	12.01	4.31	1.54	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	6.55	2.49	2.18	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.04	2.56	1.65	0.91	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	11.19	6.58	4.61	1.97	1.65	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	2.93	3.51	0.29	0.88	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	4.23	3.24	0.75	1.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	10.18	7.76	10.18	4.85	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	11.04	5.12	7.81	1.89	1.35	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.87	3.48	2.57	1.06	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	4.67	4.67	4.15	2.07	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	12.77	7.54	6.70	3.56	2.30	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	5.11	3.31	2.41	1.05	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.94	2.75	6.88	4.13	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.27	4.14	4.52	2.26	0.75	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	3.39	2.86	1.06	0.74	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	9.21	5.81	10.18	3.39	1.94	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	8.27	3.31	2.32	0.99	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	2.85	2.23	1.49	0.87	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	13.33	12.22	7.77	3.70	2.22	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.89	3.95	6.18	2.22	1.48	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	3.71	2.34	0.41	1.24	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	11.26	7.72	7.40	4.50	1.29	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	13.69	10.35	9.13	3.96	3.04	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	8.68	5.74	6.44	1.12	1.40	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.09	3.91	7.47	2.49	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	7.76	3.88	2.42	2.91	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3.27	2.02	1.09	0.62	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	6.45	4.30	4.30	2.51	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	5.55	2.94	2.29	2.94	0.98	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2.59	1.18	0.71	0.47	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	5.82	4.21	1.11	1.73	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	5.38	4.35	1.02	1.28	0.77	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	2.39	2.09	1.49	1.19	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	6.80	0.00	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	5.37	9.97	1.53	5.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.94	5.20	0.00	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	11.42	5.92	0.42	1.27	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	4.92	2.11	2.11	2.11	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	3.74	3.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	3.61	1.55	1.55	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	7.14	3.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	7.01	3.17	0.23	1.36	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	10.18	4.07	2.04	2.91	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	7.20	8.55	3.60	0.45	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	8.94	3.52	0.00	2.44	0.68	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	6.16	3.08	0.51	1.54	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	6.70	3.53	1.41	2.12	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	7.33	6.00	0.67	3.33	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	12.73	3.06	3.57	2.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	7.74	6.14	2.40	2.40	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	8.69	6.42	3.02	3.21	0.94	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	4.29	5.52	0.61	3.68	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	4.89	4.08	1.63	3.26	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	10.00	3.96	3.33	1.04	1.04	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	10.09	3.92	5.04	2.24	0.56	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	11.33	5.15	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	8.71	6.68	3.77	2.03	0.87	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	9.86	4.19	5.08	1.79	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	8.30	3.87	2.77	1.11	1.66	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	7.78	5.66	1.06	0.71	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	7.38	3.32	1.84	3.32	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	5.76	2.30	2.30	2.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	8.44	3.84	0.77	3.45	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	8.49	5.10	0.57	4.53	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	5.74	4.92	0.00	2.46	1.64	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	8.59	5.87	0.90	3.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.03	2.87	3.59	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	10.46	0.75	1.49	1.49	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	9.29	3.72	0.37	2.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	10.34	5.60	3.88	2.58	0.86	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	9.42	5.99	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	5.33	6.33	1.00	3.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	10.86	4.83	1.81	3.62	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	8.53	6.40	0.00	1.42	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	9.28	4.47	2.06	2.06	1.37	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	10.73	5.90	2.68	2.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	6.73	6.06	0.00	1.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	9.26	2.22	1.48	4.07	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	11.63	6.98	0.00	3.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	10.58	5.29	1.06	3.17	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	8.00	3.20	0.40	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	10.18	5.09	0.00	2.91	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	6.90	6.90	1.53	3.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	9.87	2.96	0.00	1.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	10.35	3.76	0.00	6.59	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	8.55	9.05	1.01	2.51	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	4.96	4.51	0.90	2.25	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	3.44	8.61	0.00	3.44	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	11.13	6.23	0.89	5.79	1.34	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	8.60	7.04	1.17	3.91	1.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	8.58	5.94	1.98	3.96	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	9.34	4.67	0.52	2.08	1.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	3.94	5.69	0.44	3.06	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	7.27	2.80	1.68	4.47	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	9.27	6.18	0.00	2.21	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	10.03	6.56	1.16	1.93	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	6.58	3.54	2.53	2.53	1.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	7.21	7.21	1.92	2.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	9.54	6.76	1.19	2.78	1.19	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	12.15	2.43	3.04	1.82	3.04	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	2.77	5.53	0.00	2.77	1.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	10.64	6.46	1.52	3.04	0.76	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	10.84	5.16	1.03	1.55	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	9.67	2.42	0.60	1.81	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	9.19	4.75	1.58	1.27	0.63	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	8.53	3.73	1.07	2.67	1.60	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	9.77	7.47	0.57	2.30	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	7.71	3.09	1.03	1.03	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	9.90	4.24	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	7.38	5.11	0.57	2.27	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	8.32	5.82	1.66	3.33	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	9.40	2.35	0.78	3.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	7.52	3.34	0.42	2.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	10.22	6.04	0.00	3.25	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	8.70	3.35	0.67	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	9.62	5.35	1.07	3.21	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	8.49	5.25	0.00	1.62	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	7.34	1.84	0.00	4.59	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	8.89	7.11	0.00	3.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	7.98	3.42	0.00	2.85	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	12.27	6.90	1.53	1.53	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	9.30	3.83	1.09	2.74	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	5.79	7.13	0.45	2.23	1.78	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	6.76	5.46	0.00	2.86	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	8.62	5.30	0.00	1.99	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	14.55	10.39	4.16	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	36.69	27.81	15.27	7.75	2.05	0.91
Macrophage - monocyte derived, donor2	11313-117C8	22.75	14.31	8.07	6.61	2.57	0.37
Macrophage - monocyte derived, donor3	11389-118C3	24.77	21.89	10.75	6.69	1.57	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	4.78	4.78	1.06	6.37	1.59	0.00
Mallassez-derived cells, donor2	11929-125I3	5.07	4.75	1.11	4.60	0.95	0.00
Mallassez-derived cells, donor3	11930-125I4	4.17	6.39	1.67	6.12	1.67	0.00
Mammary Epithelial Cell, donor1	11273-116H4	7.87	7.27	6.38	10.46	1.40	0.20
Mammary Epithelial Cell, donor2	11350-117G9	5.50	7.24	3.19	7.24	1.45	0.29
Mammary Epithelial Cell, donor3	11422-118F9	2.00	0.75	0.00	0.50	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	31.86	31.86	2.71	27.80	8.81	0.00
Mast cell, donor1	11563-120D6	39.58	32.01	16.22	11.90	6.70	0.43
Mast cell, donor2	11565-120D8	39.23	40.42	8.62	18.72	6.54	0.00
Mast cell, donor3	11566-120D9	61.68	48.85	9.00	18.24	5.40	0.45
Mast cell, donor4	11567-120E1	42.37	33.33	8.69	16.31	6.21	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	39.15	31.94	15.30	4.77	2.11	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	37.94	18.09	15.18	6.42	2.92	0.00
Mast cell, expanded, donor5	11939-126A4	47.38	36.25	13.19	8.83	2.64	0.57
Mast cell, expanded, donor8	11941-126A6	51.05	31.97	11.05	9.21	3.85	0.17
Melanocyte - dark, donor1	11502-119F8	14.33	10.85	5.07	2.79	2.79	0.10
Melanocyte - dark, donor2	11582-120F7	9.34	9.69	4.15	3.11	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	18.83	14.13	9.78	6.01	3.19	0.22
Melanocyte - light, donor1	11274-116H5	8.70	7.76	1.41	3.76	0.94	0.00
Melanocyte - light, donor2	11351-117H1	4.78	2.73	2.05	2.73	0.00	0.00
Melanocyte - light, donor3	11423-118G1	3.47	0.87	0.00	6.07	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	16.56	13.02	5.00	4.69	2.71	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	13.98	16.94	13.45	14.25	3.50	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	14.46	23.84	11.25	11.25	5.09	0.27
Meningeal Cells, donor1	11493-119E8	13.40	6.08	0.99	2.11	0.87	0.12
Meningeal Cells, donor2	11573-120E7	4.84	4.40	1.76	0.88	0.00	0.00
Meningeal Cells, donor3	11654-122E7	13.12	9.13	7.01	3.34	0.98	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	18.54	13.97	5.99	3.99	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	11.07	9.36	5.33	10.97	2.42	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	9.33	10.05	4.31	5.74	2.87	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	9.32	5.93	4.66	6.78	0.42	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	9.55	8.54	5.53	6.53	2.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	7.47	5.27	3.08	1.54	1.32	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	7.31	6.58	1.46	0.73	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	5.73	4.91	0.82	1.64	0.61	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	13.71	6.93	4.29	4.02	0.97	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	2.97	1.86	1.12	2.60	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	11.71	8.42	6.05	3.16	1.18	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	6.23	2.37	1.19	2.97	0.89	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	4.48	4.48	0.00	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	16.30	13.47	2.48	5.67	1.77	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	13.13	6.25	4.69	3.75	0.94	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	11.61	6.53	3.63	4.35	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	10.08	6.36	7.42	4.51	3.18	0.00
Mesothelial Cells, donor2	12156-128G5	6.01	5.00	0.50	3.50	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	7.95	8.38	6.21	3.61	1.52	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	18.90	14.85	2.70	22.96	5.40	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	26.35	37.43	13.55	26.60	6.16	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	24.44	28.86	5.89	18.26	4.12	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	20.74	0.00	44.94	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	22.63	28.83	5.58	22.63	4.34	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	15.56	16.59	10.99	10.58	3.94	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	4.63	0.00	9.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	25.78	33.28	13.01	17.77	3.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	20.02	19.08	3.72	13.03	3.72	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	38.93	19.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	19.51	28.65	11.38	13.62	6.30	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	19.40	19.40	5.54	13.86	3.17	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	25.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	15.04	15.93	8.85	22.12	2.65	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	16.34	18.62	14.44	13.68	4.94	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	19.74	15.79	1.32	22.37	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	16.55	24.19	12.31	19.95	4.03	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	17.50	13.81	0.00	10.13	6.45	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	13.71	21.16	6.56	17.29	3.28	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	8.38	0.00	6.71	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	33.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	19.82	22.08	14.30	19.82	4.01	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	13.55	15.21	8.08	12.12	1.43	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	10.50	12.72	0.00	11.61	2.21	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	13.58	19.80	11.05	21.64	3.91	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	15.14	15.14	5.68	12.41	1.26	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	13.66	15.90	2.24	15.49	3.06	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	13.52	18.45	10.94	14.37	4.08	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	10.45	12.23	2.67	9.11	2.45	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	13.58	15.55	7.88	17.52	2.19	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	10.14	14.19	0.00	10.65	3.04	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	9.94	0.00	18.23	3.31	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	11.69	14.40	3.26	16.04	3.53	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	12.35	19.41	3.23	11.47	1.76	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	13.08	10.90	2.18	13.08	4.36	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	10.57	15.86	7.21	17.78	2.40	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	14.81	16.01	7.20	20.01	4.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8.23	2.74	5.48	15.08	2.74	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	13.02	20.02	7.51	17.02	2.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	80.84	0.00	0.00	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	6.12	0.00	4.08	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	18.39	24.52	6.13	22.77	2.63	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	6.62	11.04	0.00	3.31	2.21	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.89	13.45	0.64	6.40	3.84	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	12.40	20.83	4.96	16.61	2.73	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.83	16.01	0.00	5.57	1.39	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	13.26	0.00	13.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	17.78	25.64	8.21	16.41	3.42	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	21.01	21.01	0.44	11.82	1.31	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	13.14	16.33	0.00	7.46	1.07	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	15.15	23.01	10.10	14.31	3.09	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	18.29	15.79	0.42	12.05	2.49	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	9.32	8.16	0.58	9.32	2.91	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	16.59	19.91	6.33	11.46	3.02	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	13.36	20.45	2.50	15.03	2.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	21.66	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	16.62	9.24	3.69	10.16	2.77	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	21.06	19.35	2.85	15.94	3.41	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	16.72	17.69	0.55	9.53	2.76	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	18.14	22.03	4.66	13.99	1.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	19.30	16.73	0.43	11.15	2.57	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.89	13.34	0.00	11.43	1.91	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	16.55	15.21	2.67	13.08	2.94	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	20.65	16.76	5.99	15.86	4.49	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	11.72	13.14	0.42	3.39	2.54	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	14.97	22.61	4.78	14.33	3.19	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	20.34	22.78	2.43	10.61	3.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.51	9.86	0.00	7.58	1.90	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	22.44	17.33	4.83	8.52	3.41	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	21.63	24.58	8.85	11.80	3.44	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	12.38	11.73	1.96	5.21	2.61	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	17.64	16.17	2.94	10.29	2.35	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	25.66	21.05	2.31	12.11	3.46	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	18.96	12.36	3.30	5.77	2.47	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.16	25.91	2.68	8.64	2.98	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	33.90	15.07	18.83	7.53	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	10.69	17.82	19.60	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	19.71	18.40	20.37	8.87	1.97	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	16.83	12.62	17.88	5.26	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	23.13	18.78	12.45	8.11	2.37	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	16.76	14.90	12.11	13.04	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	15.02	15.02	19.15	8.26	2.63	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	15.71	20.51	9.59	9.32	2.40	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	20.36	17.42	6.56	6.22	2.26	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	9.58	9.58	7.37	8.84	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	17.22	18.32	17.95	9.53	3.30	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	14.00	18.67	37.33	9.33	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	28.86	23.52	9.09	11.76	4.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	23.18	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	9.09	13.13	7.07	6.06	5.05	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	20.66	15.18	13.49	8.01	1.69	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	27.24	29.96	8.17	95.34	5.45	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	12.72	15.26	5.09	27.97	5.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	21.06	30.77	6.48	40.49	5.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	16.61	19.64	22.66	51.35	3.02	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	57.10	0.00	262.67	28.55	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	45.67	3.26	114.19	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	38.02	4.75	47.52	9.50	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	62.75	0.00	200.78	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	11.42	4.96	2.59	3.88	1.08	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	6.27	4.70	3.14	0.52	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	6.01	6.67	2.00	3.34	2.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	2.50	3.34	0.42	2.92	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	8.37	9.51	1.71	2.66	1.71	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	9.58	6.38	1.60	6.38	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.80	3.40	2.72	1.36	2.04	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	5.51	14.70	51.45	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	8.37	6.70	1.67	3.35	1.26	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	6.97	6.28	1.39	4.88	0.93	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	5.67	9.19	1.08	4.86	1.35	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	9.88	7.78	2.73	5.47	1.68	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	66.81	400.85	22.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.94	5.46	1.49	5.96	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	4.06	12.45	4.06	4.06	1.89	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	8.39	7.93	1.36	4.76	1.81	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	8.65	8.17	1.14	8.17	2.12	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	7.65	10.39	1.82	4.37	2.19	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	10.61	6.90	1.59	5.83	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	8.40	9.00	1.20	3.60	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	4.27	7.55	6.56	3.61	1.64	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	7.64	5.37	1.46	7.16	2.60	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	8.29	8.11	1.41	5.64	1.59	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	7.03	9.14	1.41	4.92	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	6.44	5.98	2.30	3.68	1.84	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	10.60	8.68	2.89	5.46	0.96	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	6.90	9.31	4.14	4.83	1.72	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	5.06	17.70	15.17	5.06	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	7.80	5.79	0.89	3.34	2.01	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	5.50	10.16	2.12	2.96	1.69	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	4.51	9.02	1.19	3.09	1.42	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.44	6.44	1.72	6.01	2.15	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	27.08	334.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	7.33	9.33	0.67	5.66	2.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	5.86	4.06	0.00	6.76	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	6.35	5.56	0.40	5.95	0.79	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	8.36	3.71	0.93	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	5.68	9.46	1.51	3.41	2.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	8.15	6.19	0.65	5.54	1.96	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.97	5.67	1.31	2.18	3.05	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	6.33	4.98	0.90	4.98	0.90	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	12.35	5.29	2.65	7.06	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	6.65	2.66	2.66	0.66	2.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	7.94	5.46	0.99	5.46	3.47	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.59	7.66	1.53	3.06	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	12.40	14.52	4.84	6.65	1.51	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	6.19	7.07	1.77	6.19	1.99	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.81	8.13	4.74	4.74	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	5.11	61.31	10.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.15	9.75	0.61	5.49	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	4.72	5.35	0.94	3.78	1.57	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	6.36	5.15	0.91	5.45	1.21	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	13.45	7.91	0.00	3.16	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	10.20	11.34	10.20	7.94	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	15.17	50.58	10.12	0.00	0.00
Myoblast, donor1	11241-116D8	9.32	8.45	3.35	4.84	1.61	0.37
Myoblast, donor2	11322-117D8	12.47	10.36	5.95	4.99	2.30	0.58
Myoblast, donor3	11398-118D3	8.74	9.92	3.20	5.72	2.02	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	21.60	12.26	15.76	4.38	1.17	0.15
Natural Killer Cells, donor1	11230-116C6	32.90	29.21	4.92	13.84	2.15	2.15
Natural Killer Cells, donor2	11311-117C6	27.14	24.73	2.71	12.06	2.41	2.11
Natural Killer Cells, donor3	11387-118C1	28.71	28.16	7.73	14.36	2.94	2.94
Neural stem cells, donor1	11275-116H6	30.85	19.60	7.26	7.26	3.63	0.00
Neural stem cells, donor2	11352-117H2	23.11	28.88	11.55	5.78	1.93	0.00
Neurons, donor1	11494-119E9	20.48	17.07	6.83	2.28	2.28	0.00
Neurons, donor2	11574-120E8	49.32	24.66	14.97	6.83	3.08	0.00
Neurons, donor3	11655-122E8	11.51	11.51	4.93	4.93	2.47	0.00
Neutrophils, donor1	11233-116C9	25.06	30.62	0.00	5.57	2.78	0.00
Neutrophils, donor2	11314-117C9	14.49	23.19	14.49	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	32.99	37.87	2.44	13.44	3.05	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	19.59	9.14	6.77	1.78	0.95	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	11.72	4.88	5.21	1.30	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	11.03	5.21	4.01	3.01	1.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	4.54	6.33	3.58	2.20	0.83	0.00
Olfactory epithelial cells, donor2	11934-125I8	5.65	6.66	2.61	3.47	0.29	0.14
Olfactory epithelial cells, donor3	11935-125I9	7.26	7.04	4.65	2.27	1.48	0.68
Olfactory epithelial cells, donor4	11936-126A1	7.01	4.68	2.53	2.63	0.88	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	10.83	12.04	3.61	3.01	3.61	0.00
Osteoblast - differentiated, donor1	11276-116H7	5.32	2.77	0.64	1.91	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	2.29	4.57	0.00	2.29	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.31	3.72	2.48	1.24	0.62	0.00
Osteoblast, donor1	11277-116H8	3.32	3.13	0.20	1.56	0.39	0.00
Osteoblast, donor2	11354-117H4	5.62	7.02	4.21	4.21	1.40	0.00
Osteoblast, donor3	11426-118G4	5.69	3.38	0.89	3.55	1.96	0.00
Pancreatic stromal cells, donor1	11249-116E7	8.68	7.58	4.97	3.29	1.35	0.08
Pericytes, donor1	11491-119E6	3.23	2.00	0.33	0.45	0.33	0.11
Pericytes, donor2	11571-120E5	4.98	3.40	0.23	0.91	0.00	0.00
Pericytes, donor3	11652-122E5	6.31	5.09	0.20	1.42	0.41	0.20
Perineurial Cells, donor1	11499-119F5	12.21	7.57	6.10	2.60	0.79	0.11
Perineurial Cells, donor2	11579-120F4	10.95	8.65	3.40	4.42	1.47	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	50.36	24.22	10.52	7.97	0.32	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	19.10	17.63	5.88	6.37	2.20	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	30.28	20.58	5.95	7.76	2.20	0.78
Placental Epithelial Cells, donor1	11278-116H9	2.63	2.87	0.72	3.11	1.20	0.00
Placental Epithelial Cells, donor2	11355-117H5	4.44	2.22	0.00	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	4.52	1.57	0.79	0.00	0.39	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	3.80	3.48	0.95	1.90	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	7.69	5.63	5.44	5.25	0.56	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	16.05	14.10	2.87	5.48	2.87	0.13
Preadipocyte - breast, donor2	11328-117E5	7.88	7.43	2.70	3.60	0.68	0.23
Preadipocyte - omental, donor1	11468-119C1	9.80	10.44	8.10	13.11	3.73	0.11
Preadipocyte - omental, donor2	11329-117E6	4.36	5.67	1.75	5.24	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	7.59	7.45	4.58	5.30	2.86	0.14
Preadipocyte - perirenal, donor1	11469-119C2	3.94	1.97	0.98	0.98	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	5.84	5.22	0.92	2.76	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	10.98	10.98	9.56	7.61	1.59	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	11.41	8.34	1.19	4.26	1.70	0.00
Preadipocyte - visceral, donor1	11280-116I2	10.62	10.99	3.82	6.52	1.77	0.00
Preadipocyte - visceral, donor2	11357-117H7	8.74	9.20	9.66	2.76	2.76	0.00
Preadipocyte - visceral, donor3	11429-118G7	7.42	6.16	3.76	6.16	1.46	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	22.33	23.83	14.93	14.78	3.62	1.06
Prostate Epithelial Cells, donor2	11331-117E8	4.33	4.47	4.20	5.82	1.49	0.00
Prostate Epithelial Cells, donor3	11404-118D9	5.39	5.51	6.37	3.06	2.14	0.00
Prostate Stromal Cells, donor1	11254-116F3	5.35	4.90	2.28	2.51	0.57	0.11
Prostate Stromal Cells, donor2	11332-117E9	7.53	8.43	9.14	3.41	0.90	0.18
Prostate Stromal Cells, donor3	11405-118E1	8.65	4.90	3.13	2.50	0.63	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	8.39	3.28	1.09	1.09	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	15.53	10.12	9.84	3.40	1.46	0.07
Renal Epithelial Cells, donor1	11517-119H5	4.57	2.03	0.00	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	2.85	4.98	0.00	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	22.66	13.76	9.00	2.86	2.01	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.72	5.45	1.36	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	6.06	4.85	2.43	2.02	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	10.66	8.88	7.10	4.00	1.55	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	2.00	3.99	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	5.28	3.08	1.32	1.10	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	7.52	3.76	2.51	1.25	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	3.61	2.50	0.83	0.55	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	9.66	8.59	3.22	2.42	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	6.33	2.95	0.84	0.42	1.69	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	8.68	6.36	1.54	1.93	1.54	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	30.85	21.26	15.04	4.93	1.81	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	15.63	6.25	3.70	2.56	0.85	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	1.03	6.17	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	23.59	14.05	17.31	4.27	2.01	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	26.99	23.92	16.97	14.70	3.47	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	9.83	16.08	5.36	5.36	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	25.32	18.71	33.02	5.50	1.65	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	17.98	12.76	2.32	6.96	2.32	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	17.81	11.18	7.41	6.76	1.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	15.29	13.70	6.55	6.55	1.69	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	21.08	15.28	13.72	9.70	1.45	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	15.88	16.62	13.02	6.82	1.74	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	17.71	14.68	9.56	6.29	2.80	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	21.03	16.18	13.17	8.55	2.31	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	10.82	10.13	5.89	5.48	1.37	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	13.77	13.77	9.38	5.75	2.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	22.04	15.23	9.14	10.03	3.58	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	12.91	12.48	10.19	5.74	1.43	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	13.74	12.02	10.19	6.01	1.82	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	16.82	16.37	12.39	7.74	2.43	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	8.99	17.21	5.54	6.31	1.72	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	15.00	15.37	5.03	6.52	1.68	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	26.12	18.60	16.72	12.21	2.82	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	15.39	11.28	2.39	5.97	2.12	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	14.60	11.49	4.58	6.33	1.46	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	17.00	17.57	15.47	8.98	3.44	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	12.39	11.32	5.55	7.05	1.92	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	11.77	12.33	7.85	7.29	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	17.43	13.33	8.20	7.86	3.25	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	12.95	10.21	4.38	9.48	1.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	14.59	10.91	8.22	6.38	1.59	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	19.21	13.83	9.00	9.40	2.42	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	12.50	14.39	12.74	6.84	2.12	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	17.46	10.71	7.54	5.16	2.38	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	22.68	14.73	10.06	11.69	2.10	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	15.34	18.45	13.48	6.84	1.45	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	15.04	11.06	3.54	6.42	1.33	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	19.22	13.58	7.52	10.86	2.30	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	15.88	13.86	12.92	6.19	1.62	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	15.16	9.88	2.21	3.07	1.02	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	18.32	15.23	9.64	7.90	3.66	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	12.55	14.44	13.76	8.08	2.58	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	15.91	14.13	3.98	7.00	2.74	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	20.03	14.12	10.51	8.54	2.79	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	13.80	15.34	7.84	8.01	1.36	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	17.90	14.94	11.24	7.40	3.11	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	13.59	15.19	9.33	9.33	3.73	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	18.53	13.69	4.84	5.39	1.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	22.38	19.29	10.71	7.38	2.86	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	24.39	16.93	6.85	10.28	3.02	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	15.63	15.16	8.10	5.56	1.70	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	24.46	12.58	12.58	7.34	1.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	22.06	14.20	8.46	4.23	2.12	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	14.69	14.81	10.04	7.34	1.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	47.74	32.02	20.23	19.50	4.22	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	15.82	20.69	10.95	7.30	2.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	13.26	15.97	9.04	6.03	1.81	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	23.52	16.29	9.50	6.56	0.68	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	26.06	23.66	17.07	8.99	3.00	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	19.72	11.10	5.90	5.43	1.53	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	17.93	16.86	5.12	5.34	2.35	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	27.64	22.84	7.81	9.01	6.01	0.60
Schwann Cells, donor1	11498-119F4	3.39	2.82	0.19	0.19	0.38	0.00
Schwann Cells, donor2	11578-120F3	13.61	0.00	6.80	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	8.33	8.54	5.04	2.41	1.75	0.00
Sebocyte, donor1	11220-116B5	2.19	3.83	1.10	1.64	2.19	0.55
Sebocyte, donor2	11301-117B5	1.38	0.92	2.30	2.76	0.46	0.00
Sebocyte, donor3	11378-118B1	3.71	3.92	2.06	2.47	0.62	0.00
Sertoli Cells, donor1	11255-116F4	9.94	6.63	3.31	4.97	1.66	0.00
Sertoli Cells, donor2	11333-117F1	19.77	0.00	5.65	8.47	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	8.18	4.13	3.70	2.11	0.53	0.00
Skeletal Muscle Cells, donor2	11358-117H8	3.61	4.34	0.72	2.17	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.03	5.85	0.00	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	9.74	8.95	4.71	3.14	1.41	0.00
Skeletal Muscle Cells, donor5	11455-119A6	8.77	5.35	5.95	2.08	1.34	0.30
Skeletal Muscle Cells, donor6	11459-119B1	10.93	9.39	3.69	5.39	1.23	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	18.27	12.22	9.58	4.91	1.39	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	11.84	7.71	5.85	2.28	0.71	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	12.10	10.81	4.46	2.78	2.28	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	6.66	4.47	2.27	2.86	0.59	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	1.45	2.90	0.72	0.72	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	4.54	3.30	0.28	1.24	0.69	0.00
Skin - palm, donor1	10286-104F7	18.80	8.06	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	4.90	5.62	0.72	6.20	1.87	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	30.26	31.08	25.35	36.81	6.54	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	4.02	2.86	0.65	4.15	1.56	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	5.00	3.48	2.64	2.78	0.70	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	2.53	4.36	1.27	3.38	0.84	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	27.49	32.99	10.36	34.25	8.88	2.11
Small Airway Epithelial Cells, donor3	11406-118E2	5.32	6.07	1.87	3.82	1.65	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	2.16	0.62	0.62	0.62	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	19.79	9.56	5.34	4.89	1.78	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	5.88	3.53	0.59	3.53	1.76	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	4.64	1.77	1.10	1.99	0.66	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	2.36	4.33	0.00	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	6.18	5.41	0.77	1.55	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	7.01	8.01	7.01	10.01	3.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	7.45	4.92	1.60	2.40	1.46	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	9.97	7.31	5.10	4.65	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	10.50	7.81	1.54	4.23	0.51	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	11.40	5.21	3.58	4.23	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	11.52	7.68	1.77	3.84	1.77	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	5.69	7.69	2.28	4.27	2.42	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.44	1.95	0.33	1.14	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	10.96	8.22	1.83	5.18	3.04	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	4.55	4.80	1.52	2.27	0.76	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.77	5.72	0.00	1.43	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	8.26	7.23	4.72	5.75	1.33	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	7.32	7.53	4.95	3.23	2.58	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	10.18	8.92	3.88	6.19	1.99	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	2.17	2.32	0.15	0.93	1.24	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	5.39	3.23	0.00	2.16	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	4.48	3.59	1.79	0.90	1.49	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	4.78	3.76	1.02	3.07	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	12.96	10.05	10.29	2.75	0.86	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	11.78	6.74	4.43	1.91	1.61	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	10.47	15.25	10.92	9.10	4.32	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	0.60	2.42	1.81	3.62	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	11.66	13.51	5.30	3.44	2.91	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	9.85	4.66	3.46	3.60	0.67	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	6.51	5.38	4.76	2.75	1.00	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	5.07	3.04	1.78	2.03	0.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	8.29	4.98	4.22	2.41	1.21	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	4.50	0.00	1.50	2.25	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	6.46	1.29	1.29	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	6.05	3.26	0.93	4.19	1.40	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	5.05	6.06	3.03	2.52	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.95	8.78	2.51	4.39	2.51	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4.13	2.06	0.59	0.00	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	8.08	7.75	3.75	2.67	1.50	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	7.47	6.07	2.80	2.80	1.40	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	5.18	2.45	0.72	1.73	1.58	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	3.82	3.57	1.27	2.55	0.51	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	2.44	2.63	0.38	1.32	0.94	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	13.56	10.62	8.66	3.91	1.40	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	8.04	6.95	4.27	4.44	2.01	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.81	2.86	0.95	2.38	1.43	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	2.94	3.91	1.22	1.96	1.22	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	8.62	4.42	4.42	6.19	1.77	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	6.73	4.97	2.34	1.76	1.76	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	7.77	12.63	1.36	8.55	2.72	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	5.29	6.08	3.17	3.17	1.06	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	8.55	10.79	5.21	2.23	0.74	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	5.75	3.95	5.39	6.83	2.52	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	7.95	13.06	0.85	7.95	0.85	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	3.94	3.94	2.76	1.18	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	7.11	6.35	3.56	4.57	0.76	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	13.58	12.38	4.39	5.99	2.80	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	7.11	6.69	5.43	4.60	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	5.96	9.17	5.50	2.75	0.46	0.00
Synoviocyte, donor1	11291-117A4	7.91	4.38	2.19	4.54	0.67	0.00
Synoviocyte, donor2	11368-117I9	7.54	8.72	3.86	2.01	0.84	0.00
Synoviocyte, donor3	11440-118H9	6.93	5.36	3.80	0.89	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	7.86	3.57	1.07	2.50	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	0.00	0.00	5.95	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	4.17	3.70	0.69	0.93	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	2.72	3.30	2.65	2.01	0.50	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	1.55	3.09	0.39	1.55	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	2.29	1.15	0.00	0.57	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	27.19	26.45	20.05	14.39	3.81	1.60
Urethra, donor2	10319-105A4	35.97	17.98	5.40	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	1.06	2.66	1.59	2.39	0.53	0.00
Urothelial Cells, donor2	11600-120H7	2.80	2.80	1.60	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	2.06	2.52	1.38	0.69	1.15	0.00
Urothelial cells, donor0	11216-116B1	9.14	9.36	5.57	3.12	0.67	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	53.39	17.80	12.46	2.67	2.67	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	50.04	30.02	7.15	2.86	4.29	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	37.65	19.85	8.90	0.68	0.68	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	40.63	24.10	18.94	3.10	1.72	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	40.67	24.98	18.59	2.91	1.74	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	56.23	22.91	13.54	4.16	2.08	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	44.97	20.19	7.34	1.84	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	31.95	30.13	9.13	0.91	6.39	0.00
Wilms' tumor cell line:G-401	10809-111A8	17.39	7.15	7.15	1.60	0.74	0.37
Wilms' tumor cell line:HFWT	10597-108E3	10.56	2.64	0.88	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	7.54	9.22	3.07	6.14	2.23	0.84
achilles tendon, donor2	10292-104G4	8.27	10.33	6.20	6.20	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	37.48	12.49	24.48	1.53	0.76	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	37.61	9.05	9.29	1.63	0.00	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	65.76	19.47	11.28	4.04	0.83	1.42
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	44.90	10.34	11.70	1.63	0.82	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	20.24	11.52	18.55	0.84	0.00	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	23.05	7.82	2.54	1.06	0.42	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	43.01	20.14	26.95	3.54	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	33.49	14.98	10.13	1.32	1.76	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	17.97	6.53	10.62	0.82	1.23	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	33.78	12.04	15.92	1.16	0.78	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	21.71	6.44	18.22	0.00	0.18	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	70.21	31.20	3.90	7.80	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	35.09	13.25	12.32	2.09	0.23	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	33.66	13.72	41.17	3.11	1.81	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	44.42	14.32	26.59	2.05	0.88	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	21.84	10.22	4.18	4.65	2.79	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	30.02	10.69	10.28	5.35	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	21.79	7.98	2.76	0.00	0.92	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	42.67	15.36	11.52	2.56	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	43.67	16.38	11.22	2.12	0.30	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	53.44	16.61	14.92	1.20	0.48	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	17.60	4.45	12.25	0.89	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	19.35	10.01	3.00	2.67	1.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	18.58	7.43	3.72	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	25.61	11.30	13.18	2.26	0.38	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	39.69	18.75	3.93	2.18	0.00	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	16.87	11.25	7.50	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	31.09	13.89	0.71	6.12	3.06	0.00
adipose tissue, adult, pool1	10010-101C1	23.73	25.13	9.00	10.24	2.95	0.31
adipose, donor1	10184-103D4	17.01	12.90	37.53	1.76	0.59	0.59
adipose, donor2	10185-103D5	49.47	21.09	8.92	4.06	1.62	1.22
adipose, donor3	10186-103D6	44.11	26.96	10.35	2.72	2.72	0.00
adipose, donor4	10187-103D7	17.34	17.34	16.47	4.33	1.73	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	22.41	6.00	4.73	1.58	0.79	0.16
adrenal gland, adult, pool1	10081-102A9	14.55	14.55	0.00	7.28	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	13.61	5.34	5.47	1.20	0.13	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	18.94	7.50	16.08	1.79	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	9.04	4.87	3.01	1.62	0.46	0.23
amniotic membrane cells, donor2	12236-129G4	10.82	5.75	3.38	2.70	1.01	0.00
amniotic membrane cells, donor3	12237-129G5	8.25	4.12	1.77	2.36	1.18	0.00
amygdala - adult, donor10196	10167-103B5	46.25	24.90	21.34	2.37	3.56	0.00
amygdala, adult, donor10252	10151-102I7	48.66	29.20	27.17	5.07	2.43	1.01
amygdala, newborn, donor10223	10360-105E9	33.25	24.53	12.91	14.52	2.26	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	17.19	13.75	7.26	12.35	1.91	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	16.33	15.88	13.68	7.72	0.66	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	31.40	16.03	23.38	25.72	2.00	3.34
aorta, adult, pool1	10052-101G7	24.32	16.67	7.45	8.43	2.35	1.37
appendix, adult	10189-103D9	64.82	56.67	13.20	83.06	16.30	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	37.49	40.93	52.28	24.08	5.85	1.72
artery, adult	10190-103E1	10.87	6.79	5.43	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	30.57	23.32	11.73	10.00	3.19	0.43
b cell line:RPMI1788	10427-106D4	42.08	17.55	13.98	6.10	1.04	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	8.32	9.16	2.22	3.33	2.50	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	17.56	8.73	6.15	8.63	1.49	0.89
bile duct carcinoma cell line:TFK-1	10496-107C1	8.20	9.37	8.54	9.71	1.51	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	13.98	8.39	6.15	2.24	1.12	0.00
bladder, adult, pool1	10011-101C2	28.25	23.25	4.67	4.02	1.30	0.11
blood, adult, pool1	10053-101G8	15.50	17.72	22.15	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	4.28	4.28	0.86	1.71	0.00	0.00
bone marrow, adult	10192-103E3	24.97	14.85	8.10	8.77	2.02	0.67
brain, adult, donor1	10084-102B3	42.03	17.43	7.18	3.08	3.08	0.00
brain, adult, pool1	10012-101C3	64.81	27.28	16.82	4.34	2.34	0.67
brain, fetal, pool1	10085-102B4	34.73	10.69	2.67	2.67	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	9.25	7.27	3.96	2.97	0.66	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	20.47	16.23	8.24	13.86	2.37	0.62
breast, adult, donor1	10080-102A8	12.00	13.89	5.05	6.31	2.53	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	8.26	6.48	6.48	1.91	1.78	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	12.99	8.97	13.61	2.47	0.93	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	34.76	13.12	16.12	13.81	0.92	2.53
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	5.33	4.84	3.15	1.94	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	30.56	14.11	16.93	1.41	0.47	0.94
carcinoid cell line:NCI-H727	10735-110B6	27.02	28.22	2.73	11.92	3.94	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	24.72	9.82	35.81	0.95	0.32	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	14.91	9.32	4.79	5.59	1.60	0.00
caudate nucleus - adult, donor10196	10177-103C6	52.96	20.72	21.88	6.91	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	52.21	23.76	17.40	3.35	1.84	0.67
caudate nucleus, adult, donor10258	10379-105H1	59.60	18.34	17.58	4.58	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	41.02	23.44	7.32	15.38	2.56	0.00
cerebellum - adult, donor10196	10173-103C2	81.57	37.87	11.65	2.91	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	82.42	48.25	26.48	8.97	5.76	0.85
cerebellum, adult, pool1	10083-102B2	35.53	21.39	13.80	2.07	0.69	1.38
cerebellum, newborn, donor10223	10357-105E6	57.29	51.48	11.62	15.78	4.15	0.00
cerebral meninges, adult	10188-103D8	38.33	15.63	8.82	7.31	2.52	0.00
cerebrospinal fluid, donor2	10294-104G6	10.23	9.50	2.19	2.92	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	11.50	5.46	4.17	3.74	1.29	0.72
cervical cancer cell line:ME-180	10553-107I4	8.45	7.95	5.30	10.94	1.82	0.83
cervix, adult, pool1	10013-101C4	31.60	28.66	13.12	6.93	1.26	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	7.66	7.11	1.95	5.85	0.98	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	0.00	3.92	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	20.75	11.06	4.35	3.36	0.99	0.50
choriocarcinoma cell line:SCH	10785-110H2	24.52	17.74	15.89	3.45	1.72	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	11.15	3.56	2.61	3.08	0.71	0.24
chorionic membrane cells, donor1	12238-129G6	8.26	9.12	2.28	2.85	0.85	0.00
chorionic membrane cells, donor2	12239-129G7	8.35	9.45	2.39	5.67	1.99	0.00
chorionic membrane cells, donor3	12240-129G8	10.44	8.79	1.65	4.95	1.65	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	27.26	16.16	7.07	1.01	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	25.16	11.53	11.53	1.54	0.96	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	22.17	17.32	6.55	2.11	2.11	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	25.68	20.80	20.03	5.91	2.82	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	22.25	24.91	17.90	6.53	2.66	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	26.47	23.01	20.36	9.57	3.66	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	34.16	15.31	17.96	7.66	1.77	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	33.62	21.37	10.95	5.73	2.87	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	42.29	12.34	24.46	3.66	0.91	0.23
clear cell carcinoma cell line:TEN	10636-108I6	18.22	14.05	8.15	12.32	3.12	0.87
colon carcinoma cell line:CACO-2	10513-107D9	16.29	15.38	10.25	11.17	2.38	0.55
colon carcinoma cell line:COLO-320	10420-106C6	69.17	23.18	20.90	7.60	2.28	0.76
colon, adult, donor1	10082-102B1	32.13	35.70	9.52	27.37	5.95	0.00
colon, adult, pool1	10014-101C5	32.90	34.08	12.81	16.92	5.41	0.94
colon, fetal, donor1	10070-101I7	33.99	40.17	24.72	14.21	5.56	1.85
common myeloid progenitor CMP, donor1	12130-128D6	82.50	64.17	0.00	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	66.71	42.07	29.75	21.25	7.22	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	38.94	22.64	15.70	7.40	2.72	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	36.24	27.22	15.51	6.91	2.12	0.85
corpus callosum, adult, pool1	10042-101F6	53.18	33.83	8.07	7.74	3.98	0.44
cruciate ligament, donor2	10295-104G7	18.64	21.07	4.86	7.29	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	12.84	11.24	3.21	3.21	2.41	0.00
diencephalon, adult	10193-103E4	28.80	12.96	13.20	2.64	1.20	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	36.28	12.63	27.09	1.38	0.00	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	20.77	8.72	5.90	7.69	1.03	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	19.74	13.72	17.09	7.22	1.69	1.20
ductus deferens, adult	10196-103E7	33.89	24.92	11.96	5.98	2.49	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	31.69	37.45	47.53	24.48	8.64	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	50.76	58.85	45.61	37.52	6.62	1.47
dura mater, adult, donor1	10041-101F5	35.51	27.75	2.06	11.56	1.73	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	28.87	35.75	27.98	58.85	5.77	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	20.06	13.18	18.77	6.45	1.58	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	33.91	28.98	4.93	6.78	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	49.04	28.15	15.74	6.05	1.51	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	46.00	35.20	4.94	13.89	2.78	0.31
embryonic pancreas cell line:2C6	10603-108E9	24.96	28.90	0.00	6.57	3.94	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	10.06	11.06	2.35	1.34	1.01	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	17.22	7.79	2.17	2.54	1.63	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	9.97	8.04	1.77	3.38	0.32	0.00
epidermoid carcinoma cell line:A431	10426-106D3	4.11	3.56	1.89	6.67	0.78	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	7.59	4.95	3.19	8.36	1.98	0.22
epididymis, adult	10197-103E8	34.54	24.28	12.35	9.42	2.51	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	3.19	4.26	1.77	0.18	0.00	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	3.54	1.97	0.39	0.79	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	11.53	9.44	12.84	3.01	1.05	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	13.98	8.56	11.52	3.44	1.57	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	13.56	13.67	10.87	4.26	2.46	0.34
esophagus, adult, pool1	10015-101C6	21.02	14.76	6.16	4.25	2.44	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	30.31	11.40	6.14	2.63	1.13	0.25
eye - muscle inferior rectus, donor1	10272-104E2	14.49	24.15	7.24	9.66	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	12.63	12.63	6.31	2.10	2.10	0.00
eye - muscle medial, donor2	10299-104H2	11.91	13.39	0.00	0.00	2.98	0.00
eye - muscle superior, donor2	10297-104G9	10.32	10.32	9.17	4.59	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	18.95	8.74	4.37	4.37	1.46	0.00
eye, fetal, donor1	10054-101G9	30.00	20.08	19.58	4.07	1.53	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	9.10	3.85	4.49	1.03	0.26	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	10.92	9.02	4.99	2.85	1.66	0.00
frontal lobe, adult, pool1	10040-101F4	68.02	31.06	20.64	7.51	3.19	0.56
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	13.81	12.31	8.11	2.70	1.50	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	18.20	7.68	5.67	1.74	0.18	0.27
gall bladder, adult	10198-103E9	39.35	46.84	7.97	20.04	8.45	1.45
gamma delta positive T cells, donor1	11937-126A2	49.93	37.58	17.18	2.15	1.61	0.54
gamma delta positive T cells, donor2	11938-126A3	43.33	32.49	7.47	4.11	1.12	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	5.28	4.01	1.06	1.06	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	28.43	24.95	6.77	10.25	2.51	0.39
gastric cancer cell line:AZ521	10549-107H9	25.41	10.17	11.31	4.92	1.31	0.66
gastric cancer cell line:GSS	10560-108A2	31.12	9.15	5.49	1.83	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	26.04	21.47	12.11	23.07	5.71	0.91
giant cell carcinoma cell line:LU65	10487-107B1	5.62	7.00	7.00	1.49	1.03	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	34.01	20.15	13.72	9.66	1.68	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	3.99	3.99	1.00	2.49	0.75	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	11.61	5.70	3.06	3.06	0.74	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	11.09	5.34	2.11	3.23	1.26	0.42
glioblastoma cell line:T98G	10485-107A8	8.72	5.52	4.30	4.64	0.66	0.33
glioma cell line:GI-1	10413-106B8	8.20	6.15	2.34	7.61	1.17	0.59
globus pallidus - adult, donor10196	10175-103C4	27.70	12.39	11.66	3.64	2.92	0.73
globus pallidus, adult, donor10252	10161-103A8	44.18	32.22	33.69	8.79	3.42	1.22
globus pallidus, adult, donor10258	10367-105F7	28.75	26.01	23.28	5.48	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	27.71	16.52	7.99	14.39	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	102.78	36.71	2.45	7.34	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	8.32	3.84	0.32	2.24	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	23.41	11.94	11.02	2.75	4.59	0.46
hIPS +CCl2, biol_rep2	14384-156C1	31.55	8.23	9.60	5.94	1.83	0.00
hIPS +CCl2, biol_rep3	14385-156C2	25.76	11.59	9.66	1.93	0.64	0.00
hIPS, biol_rep1	14380-156B6	7.19	1.44	11.50	5.75	1.44	0.00
hIPS, biol_rep2	14381-156B7	13.03	7.54	8.23	3.43	1.37	0.69
hIPS, biol_rep3	14382-156B8	35.31	14.35	18.76	3.31	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	12.07	3.45	6.03	0.86	0.29	0.86
heart - mitral valve, adult	10205-103F7	24.81	22.72	5.38	9.27	2.09	0.60
heart - pulmonic valve, adult	10206-103F8	20.13	9.15	5.75	2.09	1.83	0.52
heart - tricuspid valve, adult	10207-103F9	31.64	27.48	9.16	6.66	2.50	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	16.94	7.96	3.88	2.04	1.22	1.43
heart, adult, diseased, donor1	10051-101G6	7.24	8.09	0.43	0.85	0.43	0.00
heart, adult, pool1	10016-101C7	16.10	13.11	3.68	2.99	1.15	0.00
heart, fetal, pool1	10046-101G1	39.43	24.64	7.29	4.42	1.85	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	5.24	2.47	1.54	2.47	0.62	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	16.65	11.89	4.76	5.95	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	18.56	17.46	20.55	7.62	1.88	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	16.99	16.39	16.39	6.55	2.18	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	18.59	17.89	23.55	6.06	2.93	0.61
hepatoma cell line:Li-7	10484-107A7	14.57	14.68	11.01	11.01	2.45	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	18.69	10.75	11.76	5.53	2.21	0.10
hippocampus - adult, donor10196	10169-103B7	34.07	23.66	19.87	1.89	1.89	0.95
hippocampus, adult, donor10252	10153-102I9	45.51	22.25	24.90	7.76	2.25	0.20
hippocampus, adult, donor10258	10374-105G5	31.37	16.93	36.85	3.49	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	32.78	13.39	10.22	9.52	1.06	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	26.86	15.26	31.74	12.21	5.49	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	38.09	16.10	13.94	10.01	4.91	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	36.05	26.15	12.69	11.43	4.32	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	38.91	10.15	7.33	1.69	0.56	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	34.86	14.20	5.94	1.81	1.29	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	32.27	14.05	11.01	1.90	0.76	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	55.76	30.95	7.88	4.09	2.34	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	54.50	22.40	7.76	4.52	2.80	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	69.65	30.03	9.18	7.51	4.59	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	43.10	21.55	13.73	6.63	4.03	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	38.09	25.39	11.25	5.79	2.57	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	41.07	36.36	9.43	4.04	2.02	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	33.02	20.03	11.74	9.23	5.48	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	29.97	20.63	12.77	12.28	3.44	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	33.16	24.44	25.31	9.60	2.62	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	45.82	17.18	10.31	2.48	1.34	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	40.99	15.26	9.59	2.18	1.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	38.48	15.49	12.49	2.50	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	38.81	16.58	6.41	1.70	2.07	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	39.56	10.00	6.37	3.18	0.45	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	41.97	19.73	9.40	2.82	1.57	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	32.99	23.68	14.04	3.76	2.29	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	37.45	22.35	16.55	4.94	2.61	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	42.75	31.98	10.16	7.47	0.60	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	36.21	18.84	14.23	7.94	2.96	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	31.95	17.12	16.26	12.27	5.71	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	30.22	24.50	21.64	10.62	2.86	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	32.74	11.97	7.04	2.11	1.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	30.41	12.04	7.92	1.27	2.53	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	32.08	16.04	10.59	1.82	0.91	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	35.68	22.24	13.45	4.65	1.55	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	42.51	28.56	10.63	5.31	1.99	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	43.61	24.88	9.49	5.64	1.80	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	38.09	23.26	11.76	5.11	1.79	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	43.92	28.77	11.36	9.84	6.06	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	45.70	28.56	20.16	7.73	4.03	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	37.67	15.70	15.70	5.80	4.11	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	43.67	19.16	23.17	10.70	3.12	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	35.12	17.07	21.95	8.29	3.41	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	40.34	12.53	9.47	0.61	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	29.28	16.27	97.60	3.25	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	30.12	12.91	10.92	2.32	0.33	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	39.41	26.27	8.21	3.83	1.64	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	42.34	22.44	10.49	4.70	2.90	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	45.91	23.13	12.10	4.63	2.14	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	26.25	15.51	14.32	5.97	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	38.73	23.02	11.92	3.39	2.44	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	30.44	22.36	14.82	3.50	1.62	0.54
immature langerhans cells, donor1	11904-125F5	11.14	18.89	2.42	21.07	2.91	0.48
immature langerhans cells, donor2	11905-125F6	31.69	57.03	5.54	87.93	11.88	3.96
insula, adult, pool1	10039-101F3	70.50	32.27	11.92	8.52	2.18	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	3.58	3.58	2.28	2.28	1.30	0.33
kidney, adult, pool1	10017-101C8	29.54	28.74	12.32	10.51	3.70	0.40
kidney, fetal, pool1	10045-101F9	51.07	34.17	1.70	10.82	3.25	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	54.54	32.95	23.29	11.08	3.69	1.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	10.23	11.34	5.25	4.15	1.66	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	6.97	4.04	2.02	9.73	0.92	0.37
left atrium, adult, donor1	10079-102A7	8.17	9.26	4.90	1.09	0.54	0.00
left ventricle, adult, donor1	10078-102A6	9.61	7.08	1.52	0.00	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	11.22	4.10	3.01	3.56	0.82	0.00
leiomyoma cell line:10964C	10569-108B2	4.67	2.16	2.16	3.59	1.44	0.00
leiomyoma cell line:15242A	10570-108B3	5.98	2.72	2.72	0.54	0.54	0.00
leiomyoma cell line:15425	10571-108B4	5.34	3.16	5.10	2.91	1.46	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	6.27	8.36	2.09	9.41	3.14	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	22.31	13.69	17.83	9.44	2.48	0.94
liposarcoma cell line:KMLS-1	10782-110G8	10.15	9.22	4.06	6.40	1.41	0.31
liposarcoma cell line:SW 872	10726-110A6	11.33	6.46	1.22	1.58	0.49	0.24
liver, adult, pool1	10018-101C9	30.95	34.52	14.75	25.77	6.64	0.00
liver, fetal, pool1	10086-102B5	20.70	20.70	7.53	13.17	3.76	0.00
locus coeruleus - adult, donor10196	10182-103D2	25.37	18.08	9.62	4.96	1.46	0.44
locus coeruleus, adult, donor10252	10165-103B3	38.94	27.50	26.02	8.49	4.24	0.37
locus coeruleus, adult, donor10258	10375-105G6	31.04	22.29	15.52	7.05	1.69	0.85
locus coeruleus, newborn, donor10223	10362-105F2	31.55	25.24	18.09	7.99	1.26	0.00
lung adenocarcinoma cell line:A549	10499-107C4	10.93	9.41	5.12	6.50	1.38	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	19.30	18.61	3.45	5.52	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	21.75	10.55	2.64	1.58	1.45	0.00
lung, adult, pool1	10019-101D1	39.10	33.90	7.32	11.69	4.25	0.59
lung, fetal, donor1	10068-101I5	121.58	72.21	30.82	29.68	5.42	0.57
lung, right lower lobe, adult, donor1	10075-102A3	49.95	38.95	16.04	8.25	2.29	0.92
lymph node, adult, donor1	10077-102A5	32.66	20.83	9.47	2.84	1.42	0.47
lymphangiectasia cell line:DS-1	10727-110A7	44.27	20.82	25.21	5.70	3.07	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	47.69	17.05	12.83	3.47	1.06	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	7.65	7.65	5.95	8.49	3.40	0.85
mature adipocyte, donor1	12231-129F8	8.88	9.77	1.78	14.21	1.33	0.00
mature adipocyte, donor2	12232-129F9	11.00	8.09	1.04	12.04	1.25	0.42
mature adipocyte, donor3	12233-129G1	12.80	13.04	2.61	13.75	1.19	0.47
mature adipocyte, donor4	12234-129G2	7.11	8.16	2.11	7.63	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	32.64	23.59	10.96	18.11	3.81	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	38.35	29.33	25.94	4.51	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	57.75	34.21	25.93	5.89	1.66	1.29
medial frontal gyrus, adult, donor10258	10368-105F8	32.09	14.30	17.79	2.54	0.00	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	19.19	20.90	16.21	9.38	0.85	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	58.73	26.16	11.31	5.74	3.88	1.18
medial temporal gyrus, adult, donor10252	10156-103A3	52.21	30.98	29.07	8.49	2.33	1.49
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	26.97	11.56	21.19	5.78	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	100.48	3947.24	0.00	14.35	57.41
medial temporal gyrus, newborn, donor10223	10353-105E2	36.97	26.92	7.90	16.15	2.15	0.00
medulla oblongata - adult, donor10196	10174-103C3	22.07	24.66	11.68	6.49	1.95	0.65
medulla oblongata, adult, donor10252	10155-103A2	43.81	29.88	23.38	9.13	4.64	0.62
medulla oblongata, adult, pool1	10038-101F2	44.49	21.96	8.00	6.86	2.61	0.24
medulla oblongata, newborn, donor10223	10361-105F1	34.72	21.87	11.80	12.85	3.82	0.69
medulloblastoma cell line:D283 Med	10838-111E1	74.62	47.38	24.58	11.29	5.31	0.89
medulloblastoma cell line:ONS-76	10759-110E3	6.73	5.14	1.59	2.32	0.61	0.00
melanoma cell line:COLO 679	10514-107E1	14.23	12.65	16.39	6.47	1.15	0.29
melanoma cell line:G-361	10465-106H6	12.22	10.86	13.03	4.07	1.09	0.27
meningioma cell line:HKBMM	10691-109F7	34.73	24.78	18.81	4.70	3.08	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	87.23	50.23	27.32	17.62	7.05	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	97.21	45.88	19.18	14.00	5.44	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	6.29	4.76	2.92	3.68	2.45	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	5.45	5.27	4.36	4.91	1.27	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	8.70	4.97	5.38	2.90	1.66	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	3.93	4.35	2.95	5.06	1.40	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	4.04	7.32	4.62	3.27	1.35	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	13.19	11.11	4.86	6.25	2.08	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	5.49	6.52	3.60	9.10	1.54	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	8.63	6.90	2.42	3.91	1.61	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	6.37	4.24	2.39	2.79	0.80	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	5.94	7.97	4.19	3.78	2.03	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	7.68	7.54	2.56	5.12	1.56	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	14.16	10.87	5.27	7.25	3.62	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	8.72	7.75	4.01	3.46	2.08	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	11.17	10.47	5.93	6.28	1.75	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	7.15	4.70	3.06	3.67	1.43	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	10.42	7.19	4.67	9.71	1.80	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	4.45	2.90	4.34	2.48	1.45	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	3.88	7.30	3.65	5.70	1.37	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	7.55	8.81	5.45	4.20	1.26	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	7.77	8.22	3.89	6.72	2.39	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	8.58	7.18	5.78	4.38	1.23	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	9.94	9.57	3.68	2.95	1.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	7.15	10.59	6.30	10.59	2.00	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	8.84	6.32	2.95	2.95	1.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	7.31	1.37	1.83	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	6.65	1.79	1.53	0.77	1.02	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	5.76	2.36	1.83	1.31	0.52	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	4.01	5.55	2.46	1.54	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	4.47	3.53	2.82	0.94	0.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	4.74	2.71	3.05	0.68	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	5.89	2.36	2.36	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	5.10	2.78	0.93	0.93	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	5.48	4.04	0.58	1.44	0.29	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	4.02	2.23	1.56	1.12	0.22	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	4.33	2.64	2.64	1.44	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	2.93	1.47	0.73	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	3.02	1.34	0.34	1.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	4.50	3.68	2.46	1.64	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	6.01	2.58	0.86	0.43	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	10.33	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	3.90	2.27	0.65	0.65	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	2.91	1.45	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	2.67	0.53	1.60	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	1.64	2.45	1.64	1.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	2.72	1.94	1.55	1.17	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	4.20	6.30	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	1.99	0.00	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	2.96	0.59	2.37	1.19	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	4.87	3.66	0.00	3.66	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	3.17	3.17	0.63	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	6.21	4.48	4.48	0.69	2.76	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	6.45	4.30	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	7.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	0.00	3.44	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	6.52	2.04	2.44	0.81	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.94	1.59	5.56	1.59	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	2.36	4.13	2.95	4.13	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.68	2.18	2.81	2.81	1.25	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	9.36	1.34	4.01	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	3.55	4.73	7.10	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	0.00	2.57	15.41	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	4.13	6.88	2.75	0.69	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	5.94	7.42	2.97	2.47	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	8.97	5.61	1.12	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	3.18	3.82	3.82	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	3.22	7.66	1.21	0.81	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	6.54	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1.27	2.53	0.00	2.53	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	10.32	4.86	2.43	3.03	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	9.04	13.56	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	8.24	2.47	5.77	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	5.56	5.75	2.78	1.79	0.79	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	4.54	4.22	1.95	0.97	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	6.11	1.02	5.09	2.04	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	3.09	9.28	0.77	3.09	2.32	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	9.69	4.96	3.31	2.36	0.24	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	8.34	3.01	3.48	2.55	1.16	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	0.00	8.55	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	5.24	3.90	3.70	2.06	0.51	0.00
mesothelioma cell line:Mero-25	10850-111F4	5.90	8.62	4.31	2.50	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	10.27	10.27	3.91	3.91	0.98	0.00
mesothelioma cell line:Mero-48a	10852-111F6	6.64	7.09	4.21	1.11	1.11	0.00
mesothelioma cell line:Mero-82	10853-111F7	7.62	6.04	6.83	5.78	0.53	0.00
mesothelioma cell line:Mero-83	10854-111F8	10.72	7.32	4.60	2.04	0.85	0.00
mesothelioma cell line:Mero-84	10855-111F9	6.07	3.29	1.77	1.26	0.51	0.00
mesothelioma cell line:Mero-95	10856-111G1	5.80	5.18	4.76	0.62	1.45	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	12.59	8.78	8.12	4.97	0.66	0.17
mesothelioma cell line:NCI-H226	10846-111E9	7.96	11.95	10.32	4.52	1.09	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	12.47	6.49	11.45	2.39	0.68	0.17
mesothelioma cell line:NCI-H28	10845-111E8	19.08	7.13	6.36	2.54	1.53	0.00
mesothelioma cell line:No36	10857-111G2	12.07	5.55	8.81	2.94	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	7.32	7.32	6.50	3.52	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	23.41	12.67	5.95	3.07	0.77	0.19
migratory langerhans cells, donor2	11902-125F3	18.20	8.55	3.05	1.95	1.22	0.00
migratory langerhans cells, donor3	11903-125F4	27.28	10.59	7.36	2.33	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	4.24	8.49	4.24	2.61	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	11.44	8.48	6.15	3.60	2.12	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	5.76	2.30	0.23	2.30	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	23.98	17.13	9.90	8.37	1.33	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	24.21	10.72	9.42	2.59	0.92	0.00
myeloma cell line:PCM6	10474-106I6	31.23	13.44	17.20	1.98	1.19	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	6.09	5.58	0.51	4.06	1.52	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	6.08	6.67	3.33	4.12	0.78	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	4.35	4.68	1.67	2.67	1.00	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	3.31	4.63	1.40	1.32	0.74	0.15
nasal epithelial cells, donor2	12227-129F4	5.52	2.76	0.00	3.86	1.66	0.00
neuroblastoma cell line:CHP-134	10508-107D4	36.35	15.87	16.10	3.91	2.30	0.92
neuroblastoma cell line:NB-1	10539-107G8	14.22	12.16	6.36	5.24	1.50	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	20.25	14.13	7.80	3.80	1.48	0.21
neuroblastoma cell line:NH-12	10555-107I6	37.27	25.53	13.98	7.83	2.42	1.49
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	33.21	11.15	11.86	4.27	0.24	1.90
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	68.26	26.61	47.36	8.08	2.53	3.01
neuroectodermal tumor cell line:TASK1	10774-110F9	23.14	11.87	12.68	1.61	0.40	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	33.70	15.89	2.54	0.00	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	6.12	3.99	1.60	2.13	1.33	0.00
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	47.35	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	99.78	41.10	17.08	10.32	3.55	1.52
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	45.63	36.02	6.40	23.21	6.40	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	6.09	4.81	3.53	3.85	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	11.82	7.88	4.47	2.89	0.79	0.26
nucleus accumbens, adult, pool1	10037-101F1	68.62	26.43	13.78	6.94	1.41	0.28
occipital cortex - adult, donor10196	10172-103C1	43.27	28.85	12.36	2.06	2.06	2.06
occipital cortex, adult, donor10252	10163-103B1	53.14	32.74	32.47	7.78	2.68	1.07
occipital cortex, newborn, donor10223	10355-105E4	45.49	30.21	6.91	25.11	5.10	0.36
occipital lobe, adult, donor1	10076-102A4	52.22	25.72	23.88	7.61	3.15	1.05
occipital lobe, fetal, donor1	10073-102A1	86.68	46.34	31.75	7.29	5.58	0.43
occipital pole, adult, pool1	10036-101E9	44.39	16.48	1.97	3.71	1.18	0.08
olfactory region, adult	10195-103E6	44.71	20.63	25.60	3.82	1.15	0.19
optic nerve, donor1	10277-104E7	66.03	40.02	4.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	4.33	7.86	9.34	27.22	2.96	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	23.77	12.50	6.05	5.36	1.10	1.10
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	4.40	5.42	5.08	4.91	1.19	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	3.23	3.93	1.16	2.77	0.46	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	9.70	4.41	1.47	2.35	0.88	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	11.21	9.34	1.87	1.87	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	9.54	8.06	6.79	11.24	2.12	0.85
ovary, adult, pool1	10020-101D2	22.01	20.70	3.93	7.16	2.53	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	5.50	3.30	2.57	1.28	1.10	0.37
pancreas, adult, donor1	10049-101G4	13.17	10.35	0.94	0.94	1.88	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	17.61	11.74	9.78	2.52	3.07	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	12.78	9.54	8.35	5.28	1.19	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	18.21	19.21	7.45	13.25	1.66	1.32
paracentral gyrus, adult, pool1	10035-101E8	67.82	30.66	13.55	6.59	2.84	0.46
parietal cortex, adult, donor10258	10373-105G4	27.89	14.68	25.69	2.20	2.94	0.00
parietal lobe - adult, donor10196	10171-103B9	33.86	25.39	17.87	10.35	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	55.87	30.78	33.06	5.99	2.57	0.00
parietal lobe, adult, pool1	10034-101E7	58.95	26.17	9.43	6.17	2.11	0.00
parietal lobe, fetal, donor1	10072-101I9	60.13	36.85	31.03	6.79	3.88	2.91
parietal lobe, newborn, donor10223	10356-105E5	39.63	29.91	9.35	15.70	2.24	1.87
parotid gland, adult	10199-103F1	20.97	12.33	11.10	1.23	0.62	0.00
penis, adult	10200-103F2	23.63	18.80	8.59	7.52	1.61	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	66.75	10.78	20.82	5.39	0.56	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	11.07	7.14	5.39	2.62	0.58	0.15
pineal gland - adult, donor10196	10179-103C8	49.67	45.80	14.19	10.32	1.94	0.65
pineal gland, adult, donor10252	10160-103A7	96.53	59.22	53.89	21.91	7.70	1.18
pineal gland, adult, donor10258	10377-105G8	53.93	31.35	15.68	7.52	3.76	0.63
pituitary gland - adult, donor10196	10180-103C9	67.79	75.89	25.30	16.19	12.14	1.01
pituitary gland, adult, donor10252	10162-103A9	134.46	84.43	41.17	30.75	8.86	2.61
pituitary gland, adult, donor10258	10378-105G9	62.99	38.31	41.71	8.51	2.55	0.00
placenta, adult, pool1	10021-101D3	18.06	12.69	4.62	3.23	1.72	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	41.58	23.17	15.36	6.75	2.12	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	11.52	7.16	4.67	4.05	0.93	0.16
pons, adult, pool1	10033-101E6	52.16	25.13	14.29	8.00	3.36	0.43
postcentral gyrus, adult, pool1	10032-101E5	50.13	23.62	6.10	5.58	1.22	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	48.10	16.73	0.00	8.37	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00	0.00	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	10.78	7.43	4.22	4.52	1.46	0.00
prostate cancer cell line:PC-3	10439-106E7	15.25	19.06	10.53	16.70	4.17	1.09
prostate, adult, pool1	10022-101D4	27.66	24.31	6.98	5.53	1.27	0.36
putamen, adult, donor10196	10176-103C5	68.46	18.65	20.54	3.30	0.94	0.94
putamen, adult, donor10252	10152-102I8	31.37	33.33	7.84	3.92	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	18.58	12.02	8.74	2.19	3.28	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	50.74	14.74	13.29	1.45	0.72	0.00
putamen, newborn, donor10223	10365-105F5	30.74	17.24	17.99	9.00	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	13.09	12.22	2.91	6.11	1.45	0.00
rectum, fetal, donor1	10067-101I4	29.21	15.30	20.86	4.17	4.17	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	18.87	8.06	4.24	3.60	0.64	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	27.34	12.01	17.40	3.31	1.24	0.41
retina, adult, pool1	10030-101E3	49.10	29.92	5.67	5.96	2.29	0.40
retinoblastoma cell line:Y79	10475-106I7	41.83	15.07	24.42	2.34	1.82	1.82
rhabdomyosarcoma cell line:KYM-1	10787-110H4	16.35	11.07	7.13	6.02	1.48	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	28.12	15.18	7.87	3.94	1.12	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	6.06	4.55	0.76	2.27	1.52	0.00
salivary acinar cells, donor1	11771-123I7	5.18	5.99	1.94	4.53	1.46	0.16
salivary acinar cells, donor2	11772-123I8	7.99	7.44	3.99	6.88	1.51	0.00
salivary acinar cells, donor3	11773-123I9	9.93	9.93	1.32	4.63	1.99	0.00
salivary gland, adult, pool1	10093-102C3	30.31	17.16	9.72	3.43	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	15.68	11.80	8.26	7.76	1.85	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	13.05	12.58	6.35	7.64	2.23	0.35
seminal vesicle, adult	10201-103F3	31.74	28.04	14.81	4.76	2.65	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	32.07	25.75	9.96	10.20	3.89	1.70
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	6.54	5.03	1.76	2.01	0.50	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	6.02	7.02	3.01	2.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	23.64	20.15	18.94	7.25	1.34	1.07
signet ring carcinoma cell line:Kato III	10436-106E4	21.77	13.37	9.39	11.61	2.21	1.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	15.22	16.90	15.61	14.58	3.10	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	10.64	6.38	0.00	1.42	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	12.11	7.20	2.52	2.40	0.12	0.24
skeletal muscle, fetal, donor1	10066-101I3	10.05	6.03	2.01	0.00	1.01	1.01
skin, adult, donor1	10074-102A2	47.50	13.57	13.57	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	34.72	20.20	17.04	3.79	3.16	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	50.03	32.02	13.01	10.67	2.67	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	28.05	21.43	17.97	13.24	1.89	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	39.32	15.42	5.40	1.73	0.77	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	37.09	34.61	21.43	32.14	5.60	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	86.54	28.15	36.19	3.22	1.29	0.97
small cell lung carcinoma cell line:WA-hT	10562-108A4	8.28	6.76	4.36	3.70	1.74	0.22
small intestine, adult, pool1	10024-101D6	34.88	50.05	23.53	34.76	8.00	1.07
small intestine, fetal, donor1	10064-101I1	28.26	37.84	40.54	24.08	7.13	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	31.29	15.90	35.90	4.10	2.05	0.51
smooth muscle, adult, pool1	10048-101G3	14.73	14.73	4.65	2.07	1.81	0.52
somatostatinoma cell line:QGP-1	10781-110G7	29.75	42.62	8.31	24.39	7.77	0.54
spinal cord - adult, donor10196	10181-103D1	23.86	16.06	9.41	3.67	2.06	0.23
spinal cord, adult, donor10252	10159-103A6	34.30	26.81	18.14	9.07	3.94	1.58
spinal cord, adult, donor10258	10369-105F9	12.45	13.84	31.82	7.61	1.38	0.69
spinal cord, fetal, donor1	10056-101H2	40.86	21.34	29.88	6.10	2.44	0.61
spinal cord, newborn, donor10223	10359-105E8	18.37	17.45	14.24	7.81	1.84	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	4.48	3.58	1.49	1.34	0.60	0.30
spleen, adult, pool1	10025-101D7	39.32	23.13	12.56	4.41	1.87	0.33
spleen, fetal, pool1	10044-101F8	44.57	29.32	2.07	5.96	2.62	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	28.67	13.66	15.63	3.00	0.62	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	15.95	8.92	4.18	4.37	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	26.21	16.07	6.99	5.94	3.84	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	5.08	3.91	3.52	5.47	1.56	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	24.99	15.20	16.88	6.87	2.36	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	16.94	2.54	4.66	2.54	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	11.42	10.15	5.08	4.23	2.54	0.42
stomach, fetal, donor1	10062-101H8	28.84	44.85	13.88	39.52	6.41	5.34
submaxillary gland, adult	10202-103F4	35.32	22.22	6.84	7.41	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	1791.05	0.00	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	47.15	33.44	35.73	7.69	4.15	1.45
substantia nigra, adult, donor10258	10371-105G2	25.86	20.17	25.35	6.21	1.55	0.00
substantia nigra, newborn, donor10223	10358-105E7	36.74	16.96	9.19	12.72	2.83	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	30.95	14.21	11.92	5.96	0.69	2.06
temporal lobe, adult, pool1	10031-101E4	42.05	18.48	3.48	3.98	2.20	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	54.13	31.34	32.76	4.99	2.14	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	69.01	47.47	27.69	4.83	3.52	0.88
tenocyte, donor1	11763-123H8	5.59	5.93	2.44	1.75	1.05	0.00
tenocyte, donor2	11765-123I1	6.49	6.49	5.72	2.67	0.38	0.00
tenocyte, donor3	11768-123I4	7.78	5.56	5.56	2.22	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	22.26	9.86	13.43	3.40	1.02	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	57.81	30.83	30.83	8.17	3.24	2.31
teratocarcinoma cell line:PA-1	10807-111A6	18.29	8.37	13.02	2.79	0.77	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	66.65	36.18	21.58	17.26	6.73	1.65
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	135.01	53.70	42.36	19.66	6.43	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	38.28	25.41	10.69	17.45	5.34	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	64.16	31.92	41.69	10.75	3.91	1.95
testis, adult, pool1	10026-101D8	47.14	32.21	6.23	6.33	3.76	0.43
testis, adult, pool2	10096-102C6	75.78	51.87	19.40	8.57	4.51	0.90
thalamus - adult, donor10196	10168-103B6	30.91	19.87	17.66	8.83	2.21	0.00
thalamus, adult, donor10252	10154-103A1	48.76	38.29	31.88	9.85	3.13	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	20.02	4.62	32.33	9.24	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	21.08	13.34	9.06	2.80	1.65	0.16
thalamus, newborn, donor10223	10366-105F6	17.83	12.08	8.63	9.78	0.00	0.58
throat, adult	10209-103G2	25.97	17.98	8.99	7.99	2.25	0.75
throat, fetal, donor1	10061-101H7	30.47	14.93	19.81	4.27	1.83	1.83
thymic carcinoma cell line:Ty-82	10803-111A2	48.29	12.12	19.48	3.38	2.19	0.79
thymus, adult, pool1	10027-101D9	81.42	38.47	9.84	24.65	4.37	0.30
thymus, fetal, pool1	10043-101F7	91.12	49.67	17.14	53.82	9.87	1.35
thyroid carcinoma cell line:KHM-5M	10776-110G2	7.31	5.45	4.39	4.39	0.66	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	6.15	2.10	1.68	1.82	0.14	0.14
thyroid, adult, pool1	10028-101E1	45.72	24.45	11.66	4.57	2.33	0.00
thyroid, fetal, donor1	10060-101H6	30.58	17.40	17.40	5.27	1.58	1.58
tongue epidermis (fungiform papillae), donor1	10288-104F9	33.88	18.48	3.08	3.08	3.08	0.00
tongue, adult	10203-103F5	15.82	10.70	5.35	4.19	2.09	0.00
tongue, fetal, donor1	10059-101H5	12.22	7.88	13.01	1.97	1.18	0.00
tonsil, adult, pool1	10047-101G2	45.68	23.64	3.21	4.21	2.40	0.20
trachea, adult, pool1	10029-101E2	27.57	25.03	8.02	7.20	2.54	0.16
trachea, fetal, donor1	10058-101H4	21.54	25.77	12.31	8.08	3.46	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	6.02	2.48	0.35	3.54	1.06	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	10.23	9.32	1.11	10.54	0.91	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	28.36	14.26	17.71	7.05	2.19	1.10
tridermal teratoma cell line:HGRT	10694-109G1	7.61	0.00	0.00	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	11.68	10.24	6.43	3.81	1.69	0.17
umbilical cord, fetal, donor1	10057-101H3	16.69	18.78	0.00	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	44.02	31.91	9.90	12.80	2.73	0.34
uterus, fetal, donor1	10055-101H1	17.41	19.97	20.99	5.12	3.07	2.56
vagina, adult	10204-103F6	21.97	31.02	6.46	9.69	5.82	1.29
vein, adult	10191-103E2	36.61	21.92	7.01	7.45	2.19	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	15.49	9.88	9.61	1.07	1.87	0.80